Language selection

Search

Patent 1175809 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1175809
(21) Application Number: 1175809
(54) English Title: 2.beta.-CHLOROMETHYL-2.alpha.-METHYLPENAM-3.alpha.-CARBOXYLIC ACID SULFONE AND SALTS AND ESTERS THEREOF
(54) French Title: 2.beta.-CHLOROMETHYL-2.alpha.-METHYLPENAM-3.alpha.-ACIDE CARBOXYLIQUE SULFONE ET SELS, AINSI QUE LEURS ESTERS
Status: Term Expired - Post Grant
Bibliographic Data
(51) International Patent Classification (IPC):
  • C7D 499/00 (2006.01)
(72) Inventors :
  • GOTTSTEIN, WILLIAM J. (United States of America)
(73) Owners :
  • BRISTOL-MYERS COMPANY
(71) Applicants :
  • BRISTOL-MYERS COMPANY (United States of America)
(74) Agent: GOWLING WLG (CANADA) LLP
(74) Associate agent:
(45) Issued: 1984-10-09
(22) Filed Date: 1981-01-15
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
113,894 (United States of America) 1980-01-21
214,831 (United States of America) 1980-12-11
214,833 (United States of America) 1980-12-11

Abstracts

English Abstract


Abstract:
2.beta.-Chloromethyl-2.alpha.-methylpenam-3.alpha.-carboxylic acid
sulfone and salts and esters thereof were synthesized
and found to be potent inhibitors of .beta.-lactamases.


Claims

Note: Claims are shown in the official language in which they were submitted.


The embodiments of the invention in which an
exclusive property or privilege is claimed are defined as
follows.
1, A process for the preparation of an ester compound
having the formula
<IMG>
wherein R is benzyl, p-nitrobenzyl or .beta.,.beta.,.beta.-trichloroethyl
and n is an integer of O to 2, which comprises:
(a) when n is O and R is benzyl or p-nitrobenzyl:
heating a compound having the formula
<IMG>
wherein R is benzyl or p-nitrobenzyl in an inert, anhydrous
organic solvent, in the presence of large equimolar amounts
of a weak tertiary amine and an acid chloride, until the
reaction is substantially complete;
(b) when n is 1 and R is benzyl, p-nitrobenzyl or
.beta.,.beta.,.beta.- trichloroethyl:
oxidizing a solution in an inert solvent of a
compound having the formula
<IMG>
83

wherein R is benzyl, p-nitrobenzyl or .beta.,.beta.,.beta.-trichloxoethyl
at about room temperature by use of a peracid; and
(c) when n is 2 and R is .beta.,.beta.,.beta.-trichloroethyl:
oxidizing a solution in an inert solvent of a
compound having the formula
<IMG>
at about room temperature by the use of an oxidizing agent.
2. An ester compound having the formula
<IMG>
wherein R is benzyl, p-nitrobenzyl or .beta.,.beta.,.beta.- trichloroethyl
and n is an integer of 0 to 2
when prepared by the process of claim 1 or
dn obvious chemical equivalent thereof.
3. A process for the preparation of an ester
compound having the formula
<IMG>
wherein R is benzyl or p-nitrobenzyl, which comprises heating
a compound having the formula
<IMG>
84

wherein R is as defined above in an inert, anhydrous organic
solvent, in the presence of large equimolar amounts of a weak
tertiary amine and an acid chloride, until the reaction is
substantially complete.
4. An ester having the formula
<IMG>
wherein R is benzyl or p-nitrobenzyl, when prepared by the
process of claim 3 or an obvious chemical equivalent thereof.
5. A process for the preparation of an ester
compound having the formula
<IMG>
wherein R is benzyl, p-nitrobenzyl or .beta.,.beta.,.beta.-trichloroethyl,
which comprises oxidizing a solution in an inert solvent,
of a compound having the formula
<IMG>

wherein R is as defined above, at about room temperature
by the use of a peracid.
6. An ester having the formula
<IMG>
wherein R is benzyl, p-nitrobenzyl or .beta.,.beta.,.beta.-trichloroethyl,
when prepared by the process of claim 5 or an obvious chemical
equivalent thereof.
7. A process as in claim 5 wherein R is .beta.,.beta.,.beta.-
trichloroethyl.
8. The ester of Claim 6 wherein R is .beta.,.beta.,.beta.-
trichloroethyl, when prepared by the process of claim 7 or
an obvious chemical equivalent thereof.
9. A process for the preparation of an ester
compound having the formula
<IMG>
which comprises oxidizing a solution in an inert solvent,
of a compound having the formula
<IMG>
86

at about room temperature by the use of an oxidizing agent.
10. A process as in claim 9 wherein the oxidizing
agent is a peroxide or a peracid.
11. A process as in claim 10 wherein the oxidizing
agent is KMnO4 or H2O2.
12. An ester having the formula
<IMG>
when prepared by the process of claim 9, 10 or 11 or an
obvious chemical equivalent thereof.
87

Description

Note: Descriptions are shown in the official language in which they were submitted.


5~ DiV. II
I. Description:
The present inven~ion relates to 2~-chloromethyl-2~-
methylpenam~3a-carboxylic acid sulfone, a pharmaceutically
acceptable salt or an easily hydrolyzecl ester thereo~
which is useful as an inhibit~r of ~-lactamases.
The presumed association betw~en t:he resistance sh~wn
by ~-}actam antibio~ics to certain bas:t:eria and the ability
of those bacteria to produt:e ,B-lactamases has ~ed tu an
intensive search for ~-lactamase inhibitors. Clavulanic .
acid is an example of such a compound presently under
in~ensive study. A~o~her ~ lactamase inhibitor has in
its acid form the structure
B;!~HH3
SOOE~
and is disclosed in European Patent Application 2927
published July 11~ 1979.
- The compound having the ~tructur~
.
H2N ~c~Cl
~ . = .
Q COOH
is disclo~ed in U.S. Patents 4~036,.847, 4,009,159,
.3,993,646, 3/989,685 and 3,954,732.
,~
,

~7~
U . S . Patent 4 ,155, 912 descxibes 2-pPn~m-3-car~oxylic
acid compounds having the formula
' COOI~
and esters and salts, and see also Fa~mdoc Ab~tracts
82090A, 10336B and 44337B.
The cQmpound (under ~he number CP-45899) having the
structure
~S~f ~
rf ~ 3
~g--N
S:OOH
i~ an irrever~ibly acting ~-lactamase inhibitor with
excellent ~olution stability. It has weak antibacterial
a~tivity and potentiates the in vitro and in vivo activitieY
of amplcillin ~ersu~ ~lactamase~producing ~trains [A. R.
English e~ al., Antimicrobial ~gents and Che therapy, 14,
414-419 ~1918), ARwapokee et al., J. Antibiotlcs 31(12~,
1238-1244 (Dec. 1978) and Derwent's Fa~ndoc Abqtracts
89627A and 73866B~.
., j .
.
:
. . ' .

~5
--3--
It is disclosed by B. ~altzer et al., Mutual Pro
Drugs of ~-Lactam Antibiotics and ~-Lactamase Inhibitors,
J. Antibiotics~ 33(10), 1183-1192 (1980) that the principle
of combining ~-lactam antibiotic with a ~-lactamase inhibitor
in a single molecule functioning as pro-drug for the two
acti~e components is illustrated by the linked esters 3 and
4 in which ampicillin and mecillinam, respectively, are
combined with the ~-lactamase inhibitor penicillanic acid
sulfone. It is shown that in man these esters are excel-
lently absorbed from the gastro-intestina1 tract and after
absorptivn hydrolyzed with simultaneous liberation of the
active components. As a result high blood and tissue
levels of antibiotic and ~-lactamase inhibitor in a
balanced ratio are attained. The advantages of "mutual
pro-dxugs" over simple combinations are discussed.
Esters 3 and 4 referred to therein have the structures
~NH ~3~ CN_CH=N~
N
N
o o co
o o o
//C~CO _O
F~CO-ICH2
3

~7~
~4-
It is stated in GB 2044255 published October 15, 1980
that the invention therein relates to hitherto unknown com-
pounds of the general formula l:
H H
Rl- CH -CO -NH
~ H Cl- O - CH - A
O R~ 1
in which Rl stands for a phenyl, 4-hydroxyphenyl, 1,4- -
cyclohexadienyl or a 3-thienyl group; R2 represents a
primary amino or a carboxy group; R3 is a hydrogen atom,
or a lower alkyl, aryl or aralkyl radical, and A stands
for a radical of a ~-lactamase inhibitor containing a
~-lactam ring as well as a carboxy group, A being
connected via the carboxy group.
The new compounds are use~ul in the treatment of
bacterial infections and are in particular strongly active
against ~-lactamase producing bacteria. See also Farmdoc
Abstracts 60773C and 60776C.
Accordingly, the present invention provides ~he
acid having the formula

~7~
--5--
O O
FN~CH2Cl
OOH
or a pharmaceutically acceptable salt of said acid or an
easily hydrolyzed ester of said acid.
The pharmaceutically acceptable salts referred to
above include nontoxic metallic salts such as sodiwm,
potassium, calcium and magnesium, the ammonium salt and
~ubstituted ammonium salts, e.g. sal~s of such nontoxic
amines as trialkylamines (en g. triethylamine), procaine,
dibenzylamine, N-benzyl-~-phene~hylamine, l-eph~namine,
N,W'-dibenzyl-ethylenediamine, dehydroabietylamine,
N,N'-bis(dehydroabietyl)ethylenediamine, N-(lower)alkyl-
piperidine (e.g~ M-ethylpiperidine) and other amines
which have been used to form pharmaceutically acceptable
salts of penicillins and cephalosporins. The most
preferred salts are the alkali metal salts, i.e. the
sodium and potassium salts, and the ammonium salt.
,
As used herein the term "physiologically hydrolyzed
esters" refers to those pharmaceutically acceptable esters
known in the art to hydrolyze to the free acid ~orm ln vivo.
Example~ of suitable physiologically hydrolyzed esters
include phenacyl, acetoxymethyl, pivaloyloxymethyl,
a-acetoxyethyl, a-acetoxybenzy}, a-pivaloyloxyethyl,
,:
,

.1~ 7 5 ~ ~ ~
phthalidyl~3-phthalidyl), ind~n~l(5-indanyl)~ methoxymethyl~
benzoyloxymethyl, a-ethylbutyryloxymethyl~ propionylo.xy-
me~hyl3 valeryloxymethyl, isobutyryloxymethyl, 6-[(R)-2-
amino-2-phenylacetamido]-3~-dimethyl-7-oxo-4-thia-1-
aza~icyclo[3.2 03heptane-2-carbonyloxymethyl and
6-~(R~2-amino-2-p-hydroxyphenylacetamido]-~ dimethyl-7-
oxol4-thia-1-azabicyclo[3.2.0]heptane-2-carbonyloxymethyl.
The preferred esters are the acetox~methyl~ pi~alo~loxy-
methyl, methoxymethyl, phthali~yl, 5-indanyl, 6-~(R)-2-
amino-2-phenylacetamido~-3,3-dimethyl-7-oxo-4-thia-1-
azabicyclo[3.2.0]heptane-2-carbonyloxyme~hyl and
6-r(R)-2-~mino-2-p-h~droxyphenylacetamido]-3,~-dimethyl-7-
ox~-4-thia-1-azabicyclo~3.2.0]heptane-2-carbonyloxymethyl.
There is further provlded by the present invention
the process for the production as the desired product
of the acid having the f`o~ula
O o
. ~s~ C~2C
I ~ 'CH
~ ~OOH
or a pharmaceutically acceptable salt of said acid wh:Lch
compr~es the consecutive step5 of
a) catalytically hydrogenatingg as with
precious metal catalyst such as p~lladium,, an ester
ha~ing the ~ormula

.~7~
--7--
C~Cl
~ H3 A
o CO;2Rl
where:~n Rl is benzyl or subst1tuted benzyl and then
b) sub~ecting the hydrogenated product to
oxidation to produce said desired acid or salt thereof
and then, if desired,
c ~ esterifying sai d ~cid or salt thereof to
produce an ea~ily hydrol~rzed ester of said acid.
There is ~urther pro~ded by the present
in~ention the process for the production as the desired
product of' the acid having the formula
: '
O 1)
hC~CH2Cl
N
~, ~
a
or a pha~aceutically acceptable salt of s id acid ~hich
comprises the con~ecutive steps of
fl,) ox~d~zlng, as ~ th KMnO4, ~22 or like
peroxide or peracid, a~ e~ter havlng the i~ox~ula
Br ~C~12Cl
~N --h~
o - C- oCH2CC13

~751~
--8--
to produce an ester sul:Eoxide having the formula
~ O
Br, \\ ~ ~CH2Cl
CH~3 .
C-OC~I2CC13
and then
b) reacting said ester sul~oxide with a metal
:1~ acid, ~s with zinc in glaciaI acetic aeid, to produce
said desired acid or salt and then, if desired,
c ) esterifying ~aid acld or salt thereof to
produce an ea~lly hydrol~ze~ ster ol' æaid acid.

--9--
A wide variety of oxidants known in the art
for the oxidation o~ sulfides to sul~ones ean be used.
However, particularly convenient reagent~ for alkali
metal permanganates~ e.g. potassium permanganate,
and organic peracids, e.g. ~-chloroperbenzoic acid,
Particularly useful protecting groups for Rl are
the benzyl group and substituted benzyl groups, especially
4-nitr~benzyl. Benzyl and substituted benzyl groups can
be removed conveniently by catalytic hydrogenatio~. In
this ca~e, a solution in an inert solvent of the com~und
of the ~ormula A7 wherein Rl is benzyl or substituted
benzyl, is stirred or shaken under an at~osphere of
~ydroyen, or hydrogen mixed with an inert diluent such as
nitrogen or argon, in ~he presence of a cat~lytic amount
of a hydrogenation catalyst. ~onvenient solvents for this
hydrogenation are lower-alkanols, such as methanol; ethers~
such as tetrahydrofuran and dioxan; low molecular weight
esters, ~uch as ethyl acetate and butyl acetate; wa~er;
and mLxtures of these solvents. However, it is usual tn
choose conditions under which the starting material is
soluble. ~he hydrogenation is usually carried out at a
temperature in the range from about 0 to about 60C. and at
a pressure in ~he range from about 1 ~o about 100 kg./cm.2.
~e catalysts used i~ this hydrogenation reaction are the
type o~ agents known in the art ~or this kind of trans-
~ormation, and typical examples are the noble metals, such
as nickel, palladium, platinum and rhodium. The cataly~t
is u~ually present in an amount from about O . 01 to about
2.5 weight-percent, and preferably from about 0.1 to about
loO weight-percent, based on the compound of formula A.
It is o~ten convenient to suspend the ~atalyst on an in~rt
support; a particularly convenient catalyst is palladium
suspended on a~ inert support such as carbon. Addition-

`. ~ 5~
--10--
ally it is usu~l to bu~er the react~on mix~ure in orderto operate at a pH ~n the range ~rom about 4 to 9~ and
preferably ~rom 6 to 8. Borate and phosphate buf~ers
are commonly used. The reaction typ$cally takes about
one hour.
There is ~urther provlded by the present ~n~ention
the esters having the formuls
C~
R - CH - CO -MH
O , ~ l-o
O
~ S"` C ~ C1 ~ ~
F~CH~ H2
--O
: 8
..
wherein R i8
or Rl ~ wherein Rl is h~drogen or hydroxy and
R2 is hydrogeng hydroxy~ methyl, methoxy or chloro and
: !
`'''`

.~17S~
pre~erably the ester having the formula
~ CH~5
H-CO~ ~S ~C~
NH2 ~',
O 1=0
O O
O
~N 1, 3 7EE2
o . ~o
o
and
th~ e~ter havi~ ~he rormula
A CH~
HO ~ CH-CO-NH _~ ~
N~2 ~~"'C=O
.
O, O
' ' ~S"~ CH2Cl ! ~
~ ~ 7 TH2
o C , -.. o
8 and the
proc2ss for producing such ~n ester which comprises th~
treatmen~ with acid o:E a solution o~ a compound having
the fo~nula
. ' ~ ` .

-12-
CH~
Rl C ~ ~ CO~
2 11 0 "' f=o
R~ .
~ C~
O - ~0
O
~herein R ls
~5
or R4 ~ whereln R4 i~ hydrogen or hydroxy snd
R5 is hydrogen, hydro~y, methyl, methoxy or chloro ~ld
Rl i8 aIkyl~ aralkyl or aryl, R2 is hydrogen, alkyls aralkyl
or aryl and R3 is alkyl, aralkyl, ar~l, aIkoxy, aralkoxy~
aryloxy or R4
`~R5
wherein R4 and R5 are eQch hydrogen, alkyl, aralkyl or ar~rl
or, ~rhen taken together with the nitrogeIl atom, are piperidino
or morpholino with said treatment wlth acid pre~erably being
carrled out in an organic solvent such as acetone or
chlorofo:~ or in aqueous or partly aqueous ~olution and
pre~r~bly between pH 1 and pH 5 at room temperature.

~ 13- .
~l7;~
.
It is further preferred that, in the amino-
protecting group, Rl is methyl, R~ is hydrogen and R~
is methoxy, ethoxy or methyl; this requires the use of
methyl acetoacetate, ethyl acetoacetate or acetylacetone.
In the remo~al of the ~-~mino-protecting group
it is preferred that use be made of a strong mineral
acid such as hydrochloric acid or of ~ormic acid~
m ere is further provided by the present invention
as a novel intermediate an ester having the formula
~r ~ H2cl
-OR
wherein R i8 benzyl or substitute~ benzyl, and preferably
~p-nitrobenzyl~ and the process ~or its product$on which
comprises heating~ pre~erably at reflux, a compound
: having the ~o~mula
o
Br
~f~, ~S~1~
.' I I I .
O ~C-OR
o
wherein R is benzyl or substituted benzyl ~nd pre~erably
p-nitrobenzyl, in an ~nert~ anhydrous or~anic solvent~
pre~er~b~y dioxane, in the presence of large, and preferably
.. -

~ ~ -14- ..
~7S~
equimol~r, amounts of a weak tertiary amlne, preferably
quinollne~ and an acid chloride, preferably benzoyl
chloride, until the reaction is substRnti~lly complete.
There is provided by the present invention in
addit~on as a novel lntermediate an ester having the
formula
O
r~H2Cl
~--OR
wherein R is benzyl or sub~tituted benzyl, and preferably
p-nitrobenzyl3 and the process for its production which
comprises oxidizing a solution in an inert solvent,
preferably methylene chloride, Or a compound having ~he
formula
~r~ c~
O C-OR

wherein R is benzyl or ~ubstituted b~nzyl, ~nd preferably
p-nitrobenzyl~ at about room temperature by the use of a
peracid, pre~erabl~ m-chloropero~ybenzoic acid.

s i ~7~
--15--
. .
There is further provided by the present
inventlon a~ a novel intermediate the ester having
the formula
O O
Br ~ CH2Cl
""'r~S~'C~
O C-~C~2~
O
the pro~ess for itæ production which co~prises oxidizing
a solution in an inert solvent5. preferably methylene
chloride, of a compound having the formula
~C}~2Cl
0~ C- OC~2CC13
at about room temperature by the use of an oxidi~.ing
agent ~uch as KMhO4, H202 or like peroxide or, preferably
a peracid, preferably m-chloroperoxybenzoic acid.
"Skellysol~e B~ is a petroleum ether fraction
of b.p. 60-68C. consisting e..sentlally o~' n-hex~ne
("Skellysolve" is a trade name o~' the Skelly Oil Co. ).
The following examples are provlded solely for
the purpose of illustrating the preparakion o~ representa-
tive compounds o~ the present invention ~nd are not ko be
construeà as limiting the invent~ on.
* Trademark

~ --16--
~.~
~ 3nam-3a-carboxvlate Sulfone (BI,-P2013)
,.
O
Br~ ~ 3x, r~S
O N "~CO ~ 6~a ~~ ~
: 2 ~o;2 - ~H2~No2
:~ _
~, \ /
O
Elr,~H2cl 3r~CH3Cl
C02-C~2~ N2 ~2-C~i2~tlo2
~2
:~ 4 \/ 3
~CU3 ~ H3
N N
. ~ -~O;~H ~ C02K
(BI.-P2 û13 ,~

~ 7~
~-Bro~openicillanic Acid S-Sulfoxide ~)
1. Di~solve 30 g (37.5 mmole~ 6a-bromopenic111anic
acid N,~'-dibenzylethylenedi mine salt ~G. Cignarella et a
J. Org. Che~. 27 2668 (1962) and E. Evrard~ Nature ?01,
1124 (1964)] in ~30 ml of methylene chloride. Agi.tate ~nd
cool to 0C.
2. Slowly add 1~ ml (156 mmole) concentrated
hydrochloric acid into the methylene chloride solution.
The precipitation of dibenzylethylenediamine HC1 salt
(DBED~HCl) takes place within a minute. Sti-r the slurry
at 0-5C for 10 minutes.
3. Filter to remove the DBED-HCl precipitate
through a precoated dlatomaceous earth ("Dical te") filter.
Wash the cake with 150 ml of methylene chloride~ me
filtration should be completed as quickly as possible.
~void holding the acidic methylene chloride solution for
a~prolonged period. There m~y be some filtration problems
becau~e of the fine nature of the precipitate. Addition
of ~ilter aid to the slurry may be helpful.
4. Wa~h the combined methylene chloride ~lltrate
and wash ~ith 60 ml of cold water. Agitate 5 minutes a~d
discard the a~ueous phase. The pH of the wash is 2.0-2.~.
5. The methylene chloride solution containing
6~-bromope~icillanic acid 1s concentrated under reduced
pressure to a volume of 65-80 ml. Cool and stir the
solutio~ to ~C.
*Trademark

( -18- )
6. With vigorous agitation cautiously add 13 ml
(86.9 mmoles) of 40% peracetic acid over a period of 30
minutes. The reaction is exothermic. Maintaln temperature
between 15-18~C with ice b~th cooling. m e sulfoxide begins
to crystallize after 10 ml peracetic acicL is added. Cool
and stir the slurry at 0-5C for two hoursD
7. Filter and wash the snow white cake with the
following sequence: 10 ml 5C water, then 10 ml 0-5C
methylene chloride, ~d finally wash wlth 15 ml of heptane.
8. Dry the ca~s:e in 45C air oven to constant
weight, about 6-10 hours should be su~ficient. Extended
heatlng may generate a trace of pinkish color. The weight
of 1 is about 16.26 gm, 73.24% yield.
9. The reaction mix and final product may be
monitored by TIC uslng 15 toluene/4 acetone/l acetlc
acid (~AC) or 8 acetone/8 methanol/3 toluene/l HAC solvent
systems. me final product should be anal~zed by NMR and
IR
p-~itrobenz~1 6a-bromopenicillanate S-Sulfoxide (2)
To a 801ut~.0n 0~ 12 g ~0.0~ mole) o~ 6a-
bromopenicillanic acid s su}foxide in 100 ml o~ acetone
was added 7.5 g (0.041 mole) of potassium 2-ethylhexanoate.
~he salt was collected by filtration, washed with cold
scetone and air dried to yield a total of 10 grams. The
cr~stalline potassium salt waæ d~ssolved in 75 ml of
dimethylacet~mide and 7.8 g (0.04 mole) of p-nitrobenzyl
bromide was added. The solution was stirred at 23C for
24 hours. me mi~ture was diluted with 500 ml of water
and extracted with ethyl acetate. The ethyl acetate layer
~,,,
.
, ~ ,

--19--
~s~
was washed four times with water and dr1ed over anhy~rous
magnesium sul~ate. The ~olvent w~s e~aporated at 35C
(15 mm) to an oil which crystallized. m e light tan
crystals of 2 were slurr~ed with ether and collected by
filtration to yield 9 g (70~) mp 124-125~C dec.
. . .
Anal- calc'd for C15H15BrN206S: C, 41.98; ~, ~.05; N, 6,52
Found: C, 42.00; H, 3.48; N~ 6~98
IR(KBr): 1800(s), 1740(s), 1610(w), 1520(s), 1450(m~,
1350(s~, 1060(m), 740(m) cm~l. ~-NMR (60 mHz, DMS0): ~1.22
(s,3H), 1.6 (s,3H), 4.67 (s~lH), 5.2 ~d,~ 5 Hz,lE),
5.45 ts,2H), 5.68 (d,J~1-5 Hz,lX), 7.5-8.5 (mg4H).
p-Nitrobenzyl 2~-chloromethyl-2a-methyl-6-bromopenam-~a-
carboxylate (~)
A solution o~ 5 g (0.012 mole) of p-nitrobenzyl
6a-bromopenicillanate S-sulfoxide (2) in 120 ml anhydrous
dioxane was heated at reflux under nitrogen for 4 hours
with 1.5 g (0.012 mole) o~ ~uinoline and 1.6 g (0.012 mole)
of benzoyl chloride. The solution was diluted with 600 ml
o~ water and extracted wlth ethyl acetate. me ethyl
acetate extract was washed w~th 5% sodium bicarbon~te
olution~ 5% phosphoric acid solution and ~inally wlth
water. The organic layer was dried over anhydrous
magnesium sul~ate and evaporat~d to an oll at 35C (15 mm).
me oil crystallized ~nd wa~ collected, washed with ether,
and ~lnall~ wlth cold toluene to yield ~, 3.5 g (65%) mp
130-1~5C dec.
Anal- calc'd for C15H15ClBrN2~S C, 40-06; H~ 3.14~ N~ 6-23
~ound: C, 40.19; H, 3.12, N, 6.75
IR~KBr): 1792(s), 1740(~), 1610(w), 1520(s), 1353(s),
1280 tm~, 1025(w), 990(w), 750(w) cm
NMR (60 mHz, DMS0): ~ 1.45 (s,3~), 3.5-4.3 (m,2H3,
5.05 (s,lH), 5.42 (s~2H)j 5.5(d,J~1-5 HZ~lH)~ 5~62
(d,J~1.5 Hz,l~)~ 7.5-8~5 (~

-20~
p-Nitrobenzyl ?,B-Chlor~methyl-2a-methylpenam-6~-carbox~late
: Sul~oxide ~4)
_~.., _ .
A solution of 1 g (0.0022 mole) of p-nitrobenzyl
3~-chloromethyl-2a-methyl-6a-bromopen~m-~a-carboxylate
(3) dissolved in ~0 ml of methylene chloride was stirred
with 473 mg of (0.0022 mole) of m-chloroperoxybenzoic acld.
me solu~ion was stirred at 23~C ~or 3 hour~. Ihe methylene
chloride was evaporated to 20 ml at 15 mm and ~3C and the
concentrated solution was diluted with ~0 ml of' heptane
( "Skellysolve B" ) . ~he solvent was decanted and the residue
was slurried with ether and (4) soon crystallized yield
2~0 mg, 24% mp 136-1~7C dec.
alc'd for C15~143rClN206S ~ ~8-68; H~ 3-02; N, 6-02
Found: C, 39.14; H, ~ 5; N, 5.96
IR(KBr): 1800~s), 1760(s)~ 1520(s)~ 135~(~), 1200(s),
1050(m), 830(w), 740(w) cm 1, H-NMR (60 mHz~ DMS0):
2 (s,3H), ~.8~4.5 (m,2H), 4.97 ~s,lH), 5.25
(dzJ~1~5 Hz,~ . 5.45 (s,2H), 5.6 (d,J~1.5 Hz,lH),
7.8-8.5 (m,~H).
Potassium 2~-Chloromethy -2~-methyl~en~m-3a-carboxylate
Sulfone (5) (BL-P201~)
To a ~olution o~ 7 g ~0.015 mole) o~ p-nitrobenzyl
2~-chloromethyl-2a-methyl-6a-bromopenam-3a-c~rbox~late
sulfoxide (4~ in 150 ml o~ ethyl acetate ~as added a
suspension o~ 4 g o~ ~0% palladlum on diatom~ceous earth
("Celite") and 2.8 g of sodium bicarbonAte in 150 ml of
water. The mixture was h~drogen~ted for 3 hours at 50 psi.
; .

( -21-
~7S13~9
The catalyst was separated by filtration and the aqueous
layer wa~ sep~rated and treated with 1.5 g of potassium
permanganate in 50 ml of water. The ~lxture was stirred
for 1 hour and 250 mg of ~odium bisulflte w~s added. m e
mixture was ~iltered and the filtrate was ad~usted to
pH 2 wi~h c.oncentrated hydrochloric acid. The solution
w s lyophilized to give a white amorphous powder. The
solid was extracted with ethyl acetate, evaporated to a
volume of 20 ml ~nd diluted wlth 100 ml of heptanes
("Skellysolve B"). Whi~e3 hygroscopic, solid 2~-
chloromethyl-2a-meth~lpenam-~a-carboxylic acid sul~one
was collected. The ac~d was dissol~ed in acetone and
treated with solid pot~ssium 2-ethylhexanoate. A
crystalline white salt precipitated to give, after
~iltratlon, 170 mg of 5 m2 ~140C dec.
Anal~ calc'd for C8 ~ ClKN05S'2H20: C, 28.27; H, ~.24; N, 4.12
Found: C, 28.27; H, 3.69; N, 3.84
IR(KBr): 1790(s), 1770(m), 1620(s), 1460(~, 1370(s)~
1~10~s), 1200(s), 1140(s), 955~m)~ 740(m~ cm 1, H-NM~
(100 mHz, D20): ~1.68(s,3H)3 3.2-3.9 tm,J~2~z~ æ~
J~6.Hz~2H)s 4.0-4.4 (m,2Hj, 4.~ (s,lH)9 5.02 (d d, J~ Hz),
J~2 Hz,IH)~ ~
... . .
P~valoyl;ox~methx~ 2B-Chloromethyl-2-methyl,~enam-3~-
carboxylate Sul~one
2~-Chloromethyl-2-methylpenam-3a-carboxylic
acid sulfone in dimethylormamide is treated with one
eguivalent of triethylamine and stirr~d to effect solution.
Bromomethyl pivalate (1 equivalent) ;n dimethylformamide

1 ~22-
~L7~
is then added. The resulting mixture i5 stirred at room
temperatura. m e mixture is then ~larified by filtration
and the filtrate pour~d in~o ice w~ter~ $he separated
solid is collected by iltration, washed with water and
dried to give the title ester.
The respective acetoxymethyl, methoxymethyl,
acetonyl and phenacyl esters of the ~ame acid are
prepared by substituting in the method ahove for the
bromomethyl pivalate used th~rein an e~uimolar weight of
chloromethyl acetate, chloromethyl methyl ether,
~hloroace~one and phenacyl bromide, respectively~
~,
Pivaloyloxy~ethvl 2~-Chloromethyl-2-methYlPen~n-3~-
9b9L~ 9~'ea~ BL_P2024
:
O
~ ~y ~CH3
~,S !~ O
0 ~ 2CI ~ NaI ~ N2 ~ ClCN2-0-C-C~CN3)3 c~
~BL--rP:!013 )

-23
H3
~ P~
C0 C~ -0 C-C(CH3)3
tBL-P2024)
To a ~tirred suspension of 14.fig (0.0487 mol)
of BL P2013 (5) in 200 ml of acetone W?~ added 4 ml of a
10% aqueous ~olution of ~odium iodide and th~ mixture was
broùgh~ to reflux on the steam bath. To this refluxing
suspe~ion was added 14.8 ml ~0.1 mol) of xedistilled
chloro~et~yl pival~te (~.P. 34C at 7 mm Hg) all at once.
The mixture was stirred at reflux for three hour~ and ~hen
cooied to room t~mperature ~22~C~ The crystalline ~olids
were collected by filtra~ion, washed with 3 x 30 ml of
a~etone and the combined fîltrates were evaporated in a~
oil in vacuo at ~22C. The oil was then ~aken up in 500 ml
o~ ethyl acetat~ and washed once with watex t200 mll and
once with ~aturatea Na~SO4 while being stirred with 2 g.
o~ decolorizing carbcn with cooling tice bath). A~ter 20
minute~ the mixture was filtered through a diatomaceous
tDicalitel pad with ~uction and the pad wa~ washed with
4 x 100 ml of ethyl acetate. The combined filtrate~ were
concentrated in vacuo at 22C to an oil. The oil was then
.,, , , . ~

-24
S~
conoen~ated further at about 22C and cl mm ~Ig to r~nove
most of the re~idual chloromethyl pivalate. Th~ remaining
oil was th~n triturated t:wice with 50 ml portions of
n-pent~ne and then l~f t over 'che weelcend in the cold room
(about lObC) under n-pentane. The ~olid cry~talline mass
wa~ therl broken up ~o a ~olid powder under 40 ml of
4:1 mixture of ether-n-pentane. The product was ~hen
collected by filtration, washed with ether~p~ntane (1:1)
the~ pentan~ and air dried . af te:c drying ir va uo f or
four hours over P205 there wa~ obtained 13.37g. of
pivaloyloxymethyl 2~-chloromethyl 2a-methylpenam-3u
carboxylate sulfone (about 75% yld) M.P. 93-95C.
nal- Calc~- for ~14H20~lNo7s: ~:, 44.03; H, 5.27; ~, 3~;7n
Found- C, 44.11; H, 5.0~; Nr ~,.85.
Example 4
Rec ~allization of Po~assium 2~-Chlorometh 1-2~-
m~=~
To a mixture of 20 ~nl of n-butanol and one gram
of ~L-P2013 (S) was add~d water, one ml at a time, wi.th
shaking in ~ separatory fun~el until a pale yellow solution
wa~ obtained. The clear solution was filtered throucih
a 1uted filtOE paper and the flask and ~ilter paper washed
~lth about 10 ml of 9:1 n-butanol-H2O and the combined
filtrates were diluted wi th a furth~r 20 ml o~ n-butanol.
The resulting ~olution was placed in a round-buttomed
flask on the roto-vap and evaporated under reduced pressure
to approxima~ely one hal the original vo:Luma~ The ~now
white crystalline product was collected by ~iltration, wa~hed

-25-
~7~
with 6 x 10 ml of ace~one and air dried. Yield 810 mg.
After vacuum drying 6 ho~rs over P2O5 at ~1 mm H~o
there wa~ obtai~ed 800 mg MoP~ 215~C ~dec.) (B0% yld)O
Anal. Calcd. for C8HgClN05SKolH~O C9 ~9.67; Hp 3.39; N, 4.63;
Cl~ :10.94; R~F.H2O~ 5.56.
Pound: ~, 29.23; }I, 3~38; N, 4.49;
Cl, 10.74; ~F.~2O, 5.74.
Thi~ recry~tallization procedure produces a
cry~talli~e monohydra~e differing from ~he ~tar~lng
material whi~h i9 esxen~ially anhydrou~.
.
Exam~le 5_
O O
Il C12 ClC ~ C-Cl
CHL0-C-Cl ___________~
3 llght
1 C 3
O
ClC ~ -0-S-Cl
See Chemical Abstr~cts 27, 24271 and 22, 3828; a~d
GB 299064~

-26- ~)
7S~
ClSO 5CH2Cl (6
o o o
hCH3 ~ '` F
~OOK 8-OG~Cl
. 7
NaI
ac etone
O ~ ,0
~C~2C
CH3
'C, OCH2I
O
8 ~ ~C~-CO-N~
rCOOK
H:3C N
~1 5
El C~ C~
I
OCH~ '
9 (U.S. Patent 3,316,247)
I

--27-- `I
~7.~g
~CH--CO--NH = ~
N O C=O
~C-17'~ l
H C~C ~
OCH3 0
`'S~ C~2Cl
~CH3, ~H2
O
~I
/9 C~
~CH CO~ ~CH3
o CGO
",_. I
o
:Ll o O
~N2

-28-
~ ) A solution of chloromethyl chlorosulfate (0.115 mol)
in 40 ml. dichloromethane is added dropwise~ keep~ng
the reaction temperature below 30C., to a s olution of
compouna 5 (0,1 mol) ~d potassium bicarbonate (0.~ mol)
and tetrabutylammonium hydrogen sulfate (0.01 mol) in
200 ml. dichlorometh~n~-water tl:l). At the end
of the addition the mixture ls stirred at roo~ temperature
~or ~0 mi~ute~, the organic phase i~ separated and the
a~ueous phase is extracted with dichloromethane (50 ml.).
me c~mbined organic phases are dried (Na~ 04) and ~vaporated
in v~cuo to giYe a residue which is d~sol~ed ~n ether
(150 ml.). Insoluble material is filtered off after
add~ng diatomaceous earth and the filtrate is e~aporated
in. acuo to provide compound 7.
b) To a ~uspen~ion o~ compound 5 (1.~ g.) in
d~meth~l~ormamide (12 ml.) there is added 1.6 g. bi~-
chlor~methyl sulfate and the mixture is ætirred at room
t~mperature for 45 minutes. After dilution with ethyl
acetate (50 ml. ) the mixture i8 washed with water and
then aqueous ~odium bicarbonate, dried and evaporated in vacuo
to leave compound 7 a~ ~n oil.
c) To a solut~on of compound 5 (0.005 mol) in
dimethylformamlde (7.5 ml.~ there i8 ~dded triethylam~ne
(0.007 mol) ~d chloroiodomethane (0.0~0 mol) and the
mixture i~ stirred at room temperature for ~our hours.
~tsr dilution with ethyl acetate (30 ml.) the mixture
i8 wa~hed with water (3 x 10 ml. ) ~ollowed by saturated
aqueou~ sodlum chloride (5 ml.), dr~ed and evaporQted in
vacuo to leave compound 7 a~ an oil.
____

i -29- ~
. d) To a mlxture of compound 5 ~0.15 mol) silver
nitrate (0.15 mol) and ~ilver oxide (7.5 g.) in acetonitrate
~750 ml.) there is added chloroiodomethane (1.5 mol).
After stirring for ~8 hours at room temperature, the silver
salts are flltered off and the filtrate is evaporated
to dryness ln vacuo The resldue is dlssolved in ethyl
acetate (200 ml. ) ~nd the solutlon is washed with saturated
aqueous sodlum chloride, ~iltered, dried and evaporated
in vacuo to gl~e compound 7.
.
Compound 7 and other intermediates and ~inal
products of the present invention are pur~ied, if desired~
by column chromatography, as on "Sephadex" LH20 using
chloroform-hexane~ 65:35 as the eluent for exemple or by
silica gel chro~atography, e.g. using Mallinckrodt
CC-7 and hexane-ethyl acetate, 3:2 or ethyl acetate-
petroleum ether, 8:2 or 7:3 or 1:9 or 15:8~ or ethyl
acetate-n-hexane, ~:6 or ~:1 hexane-ethyl acetate, ~:1
or 1:1 or 1:4 or cyclohexane-ethyl acetate, 1:1.
Thin layer chromatography is also uQeful.
"Sephadex" is cross-linked dextran 2-~diethylamino) ethyl
2-~r2-(diethylamino)ethyl~diethylammonlo}ethyl ether chloride
hydrochloride epichlorhydrin (See Merck Index, Ninth Edition,
item number 7337)
.
A 801ution oi~ compound 7 (0.2 mol) and sodlum
iodlde (0.~ mol) in ~cetone (150 ml.) i8 stirred at room
temper~ture for 18 hours. The resulting suspenslon is
coaled to about 0C. and ad~usted to about plI 7.2 by the
addition o~ saturated aqueous ~odium bicarbonate with
stirrinæ. After decolorlæing by titration with 0.5 M
aqueous sodium thiosulfate, water (150 ml.) is added
~ropwi~ to the stirred mlxture to precipitate solid
compound 8 w~ich 1~ collected by filtration, washed with
acetone-water 1:1 (2 x 20 ml.), lsopropanol (2 x 20 ml )
and ether (2 x 20 ml.) and dried.
.

--30-- j
~Q~
Ampicillin is converted to compound ~ by the
use o~ methyl acetoacetate in the proc~dures Or U.S.
Patent 3,316,247. Then to a stirred solution of c~mpound
2 (~57 mol~ in d~methyl~ormamide (1 liter) there is added
at 5C. 0.5 mol of campo~ld 8. ~fter stirring for 15
minutes at 5C. the reaction mixture is poured into an
ice-cold mixture of ethyl acetate (4 liters) and saturated
~queous calcium chloride (2 liters) ~ith stirring. The
organic layer is separatedg w~shed with saturated ~queous
c~lcium chloride (2 x ~00 ml,), ~iltered a~d evaporated
to abou~ one liter in ~acuo to provide ~ concentrated
solution o~ compo~nd 10. To thls concentrate there is
added water (500 ml.~ and n-butanol (500 ml.) and then,
dropwise, 4 N hydrochloric acid with stirring until
the ~mino-protecting group is remo~ed to provide a solution
of compound 11. After the addition o~ the acid is ~ini~hed
ether (1 liter) and water (500 ml.) are ~dded to the ~tirred
mixture, the aqueouæ phase i~ separated and the organic
phase is e:x:trac*ed with water ~800 ml. ). The c~mbined
a~ueous extracts are wa~hed with ether (1 l~ter) and then
sodium chloride (640 g. ) and di chloromethane ~2 liters ) are
added and the m~ture i8 stirred ~or 15 minute~. Ihe
organlc phase is separated and the aqueous phaæe is
extracted with dichloromethane (1 liter) and the com~ned
organic extracts are dried(MgS0~) ~nd evapora~ed to
about 600 ml. under reduced pressure to give a concentrated
~olut~on o~ compound 11. Additlon to the conc~ntrate
o~ 200 ml.2 butanona followed by coollng precipltate6
~olld 6-~(R)-2-~min~-2~phenylacetamido1-3,3-d~methyl-7-
~oxo-~-thia-l-azabicyclo~3.2.0Jheptane-2-carbonyloxymethyl
2~-chloromethyl-2-a-methylpenhm-3a-carboxylate sul~one
(11) which is collected by ~iltration.

-31-
ExELm21e 6
6-C~R)-?-Amino-2-p~hydr xyphenylacetamido]-3,3_
dimethyl-7-oxo-4-thia-1-azabicyclor3.2.0]heptane-2-
carbonylox~methyl 2~-chloromethyl-2-a-methylpenam-3a-
carboxylate sulfone having the formula
~o _~C~--CO--N~ ~CH3
NH2 0 C~O
O
~: .
is produced by substituting ~moxicillln for the
ampiclllin used in the procedure o~ Example 5.
.

( -32- !
3~
ExRmple 7
CH2
. ~ N-Bromo~uccirlimide
o
a-~zo-isoblltyronitrile
CC14
~ ~'
CH~Br
O
~ AS taught by U.S~ Patent 3,860,579, recrystallized
; phthalidP (50 g.~ 0,~75 moI) and recry~tallized N-brom~-
succinimlde (0.37~ mol) were refluxed by 4.5 hours ln
the presence of about 100 mgm a-~zobutyronitrile in one
liter CC14. The mixture was cooled to about 1~C. and
~iltered to remove succinlmide which was itsel~ washed
with about 100 ml. CC14 and ~iltered. l'he c~mbined CC14
phases were concentrated in vacuo to about~ 150 ml. giving
501i~ ~-bromophthalide which was collected by ~iltration3
wa~hed with about 50 ml. CCll~ and ~ir-dried to yield 54 g.
which weigh~d 50 g. a~ter recrystallization froq~ boiling
cyclohexane, m.p. 84-86C.
b)
.. .. . _ _ .. . . ..
O O
CHBr ~~
C;zCl ~o
C-OK
_ DMF
22C.

( -33~
~7~
o o
~S~ C~2~1
'CH
~ N ,~ *
u ~-0-CH ~ BL-P2036
O O l
R ~ ' *dl
O
To a stirred partial soluti~n and partial suspension
of compound ~ (BL-P2013; 2,~ g.7 0.0075 mol~ in 20 ml,
d~methylfo~mamide (DMF;. ~ried at least ~ weeks over 3A
molecular seives~ wa~ added 1.7 gO (o.oo8 mol) o~
3-br~mophthalide (12) and the mixture was stirred 4 hours
ht 22G. The resulting mixture was poured into a mixture
of 200 ml. ice-cold water and 200 ml. ice-cold ethyl
acetate (rlnslng the fla~k with a little ethyl acetate)
and the ~ixture was shaken. Then the organic solvent phase
was separated ~nd washed with seven portions o~ ice-cold
water (lOO.ml.). The ethyI ac~tate phase was ~shèd o~ce with
saturated aqueou~ Na~S04~ dried ~n the cold o~er Na2S04,
filtered and evaporated to dryness in vacuo to 12a~e as the
residue ~n oil which was triturated twlce with methylcyclo-
hexan~ (25 ml.)9 twice with "SkellysQlve B" (b.p. 60-68C.,
essentially n-hexane~ (25 ml.) and ~our times with 25 ml.
n-hexane to 2.5 g. compound 1~ as a nearly white solid
after drying ~n a~r. Thi8 product was then dried over
P20~ at less than } mm Hg to gi~e 2.5 g. c~mpound 13,
m.p. 104C. (dec.). It~ estlmated purity was 85-95%.

~ 34-
~7~ g
Anal. Calcd. for C16Hl~ClN07S: C, ~1.61, H, ~.79; N, ~.77;
Cl, 9.5~.
Found: C, 52.59; H~ 4.67, N, 3.21;
Cl~ 7.r3; K.F.~20, 0.27.
.. . .. . .
P ~aloyl~ ethyl 2~-Chloromethyl-2a-methylpenam-~a-
C ~lrb ~a ~9~Y~Df ~
A mixture of 1 g~ ~0.0031 mole) of potassium
2~-chloromethyl-2a-methylpenam-3a-carboxylate sulfone
hydrate and 1 g. of ~A molecular sieves was stirred in
15 ml. o~ dimethylacetamide ~or 2 hours at 2~. To
this mixture was added ~70 mg. (0.0031 mole) of
pi~aloyloxymethyl chloride and the stirring was continued
for 18 hours. me molecul~r sie~es were collected and
the ~iltrate was diluted with 100 ml. of water ~nd ~xtracted
with ethyl acetate. The ethyl acetate was wa~hed nlne
times with water and dried:over anhydrous magnesium æulfate.
The solvent ~as removed at ~0 (15 mm) to le~ve an oil which
was chromatographed on silic~ us~ng silicar CC-7 (methylene
chlor~de 8, ethgl acet~te 2) showing 1 spot Rf .5. me
residue obtained cr~stallized from heptane ("Skellysolve
B") to yield 100 mg. (M.P. 94-95) of pi~al~yloxymeth~l
2~-chloromethyl-2a--methylpenam-~a-carboxylate sul~one.
Anal. Calcd.: C, 44.0~; H~ 5,27, N, 3.67.
Found : C, 44.20, H~ 5.24; N, 3.6~,
~he NMR and IR spectra were consi~tent ~or ~tructure.
,

-35- -
S~
Sodium ?~ Chloro~eth~1-2a-meth~ylpenam ~a-carboxylate
Sul~one
~ CH2Cl I H~ NaEH~ ~ CH
CH
N _ ~ C2
2 C8HgClN05SNa
(306) (2~9-673
__ _ _ .
To a stirred solution o~ 500 mg. of BL~P201~5
(potassium salt) in 5 ml. o~ H20 and 10 ml. o~ ethyl
acetate was added 2N HCl until pH 1 was obtained (done
in an ice-bath with vigorous st:lrring). The mi~cture was
then saturated with Na2S04, the aqueous layer separated
and the organic phase dried briefly in ice over Na2S04,
~lltered and treated dropwise with 50% NaEH (sodlum
2-eth~Flhexanoate ) in anhydrous n~butanol until neutral to
moist pH paper. Product did not crystallize upon scratching and
was then concentrated in vacuo to a~ oil which ~E~3 dissolved
in acetone (5 ml.), scratched - no crystals, ether added to
cloud point - no cyrstals. Concentrated in vacuo on
rotovap. to ~n oil which was di~solved in ethyl acetate -
added one drop H20 - scratched - no cry~tals. Concentrated
ln vacuo and then resldue was triturated wlth 5 ml. of
~-butanol - 200 mg. o~ amorphous white powder obtained~ ether
washed - air drled - vacuum dried over P205 for 24 hours.
180 mg. ~inal yield o~ sodlum 2~-chloromethyl-2a-methylpenam-
3a-carboxylate sulfone; dec. pto ~100 inde~.
Anal. Calcd. for C8H~ClN0 SNa: C, 3~.10; ~, 3.1~; N, 4.89
Found: C, 33.~0; H, 3.69; N, 4.44
K.F~ ~ 0, 4.04

-36-
~7~g
Exampl~ 10
Potassium 2~-chlorome~ 2-meth~y~penam-~-carbox~late
Sulfone (BL-P20133
To 10 L of water~ 1~0 g. (1.25 mole) of sodium
hydrogen carbonate and 200 g. o~ 10 % Pcl on BaS0~ were
added 272 g. (o.565 mole) o~ p-nitrobenzyl 6a-bromo-2~-
chlorometh~l-2-methylpenam-7-carboxylate sul~on~ dissolved
in 5 L o~ ethyl acetate. The mixture was hydrogenated
at 40C and 1 Kg o~ pressure. A~ter 5 hours, the hydrogen
uptake became very ~low and 200 g of 10% Pd on BaS0~
were ~dded and the mixture hydrogenat~d untll no ~urther
signi~icant hydrogen ~bsorption was perceptible.
.
The slurry was ~iltered through a diatomaceous
earth ( "Celite " 5 pad, the pad w~s washed with water and the
aqueous ?hase washed with 3 L of ethyl acetate. To the
aqueous solution, 3 L o~ ethyl acetate were added and the
pH o~ the mixture adJusted to 1.5 with 150 ml o~ 12 N HCl
at 10C. The org~nic ph~se was separated and the aqueous
solution saturated with Na~S04 10 H20 and extracted with
2 x 1 L of ethyl acetate. The ombined extracts were
dried with magnesium sulfate. me dry~ng agent was remo~ed
and 260 ml of 2 N pota~sium 2-ethylhexanoic acid in butanol
were addsd at 0C.
A~ter stirring 2 hour~ at 0C, the potasslum 2~
chloramethyl-Z-methylpenam-3-carbo~ylate sul~one (BL-P2013)
was collected and dr~ed in a vacuum at room temperature~
~ ield : 134.~ g (about 70~).
*Trade~ark

--37~
~ ~7~9
Example 11
p-Nitrobenzyl 6c~-Bromopenicillinate Sulfoxide
__
. _ _ ......... .. . . .
o
(101)~-~2
*02H ~216 )
~296) ~ /
~: O
Br" ~ S ~
N ~ "~ ~===\
O C02CH2~ ~ N2
1.28)
... . . . . .. .
Procedure:
To 200 ml. of N~N-dimethylacetamide was added
44 g, (o.L48 mole) of 6a-bromopeniclllanic acid ~ulfoxide
followed b~ 20.5 ml. (0.148 mole~ of trlethylamine and
38.2 ~. (0.177 mole) of p-nitrobenzyl bromide. It ~was
~tirred at 22 ~or 20 hours~
The reaction mixture was poured into l llter H20
and extracted into 3 x 300 ml. of methylene chloride. The
comblned methylene chloride extracts were washed with 200 ml.
of 5% aqueous ~odlum bicarbonate solution and dried over
~odium ~ul~ate at 5 for half an hour. me solution was
fllsered and ev~porated under vecuum to a resldue. The
- .. . .
. ~ ~

~ 38-
~7S~
. .
residue was diluted with ether and the soIid coliected by
~tltration to yield 54 g. p-nitrobenzyl 6a-bromop~nicillinate
sulfoxide after drying.
85% y~eld.
nmr conslstent for structure,
me yield ~or this ~tep was the same a~ for the K-salt
esteri~icatlon. The advantage i~ there wa~ no need to
make the K-salt. (A step which goes in 85~ to 90~ yield).
Pr~paration of~ itrobenzyl 6a-Bromopenicillanat~ Sulfoxide
To 4.~75 L o~ N~N-dimethylacetamide wa~ added 873.o
g (2.95 moles) of 6a bromopenicillan~c acid ~S) sulfo~ide and
then with stirring and while keeping the internal temperature
below 35C~ 29~ g (2.95 moles) of triethylamlne ~oIIowed by
764 g (3054 moles) o~ p-nitrobenzyl bromlde. The mixture
was stirred then at room temperature for 5 hour~ and let
stand overnight.
The reaction mlxture was poured lnto 20 L of wa~er
and extracted with ~ x 7 L Or methylene chloride. The
combined organic e~tracts we~e wa;hed 5 x 7 L of wat~r and
then with 7 L of . 5% aqueous sodium bicarbonate solutlon and
dried over anhydrou~ magnesium sulf~te.
The magneslum sulfate was filtered o~f and the
solution evaporated to a crystalline residue; 4 L of diethyl
ether were added ~nd the cryst~ls collected to y~eld a~ter
drylng ~t room temperature 1171 g (92%) o~ p-nltrobenzyl
6a-bromopenicillan~te sul~oxide.
Br 18.~8% (calculated 18.53%), ~ (0.25% MeOH).+ 162.
. .
. .

--39--
~ 7~
Example 13
Preparation of p-Nit~obenz~:~
2 -me t?~ylpenam-3 -c~
To 16 L o~ acetic acid w~s added 364.6 g (0.812
mole) o~ p-nitrobenzyl 6a-bromo-2~-chloromethyl-2-methylpenam--
~-carboxylate. To the solution so obtained and stirred at
room temperature, a 601ution of 282 g (1.78 mole) o~ KMnO~
in 26 L o~ water was added drop~ise over ~ hours. me
mixture was then stirred at room temperature ~or 1 hour
~nd H202 (~7%) was added dropwise until a colorless solution
~ wa obtained~ 30 L of water were th~n added, the mixture
: stirred ~or 1 hour ~t ro~m ~em~erature~and the cr~stalline
:~ precipitate was collected,.washed with 3 x ~ L o~ water ~nd
:~ with 2 x 2 L of ethanol and dried o~er vacuum at room temper
: ature.
Yield: 297 g (76j¢)
~: ~ : aD (~5% CH2C12) ~ 75.g
: ~ :
:
Preparatlon o~ BL~ ~ee Acid
~C~12C1 ~3pO~ S~,CH2Cl
r~ E~s ~ ~ I CH~
d~ "~C02~3K~ ~ '~C02H
. ., ...... , ,.,~ . ~.. ..... ..
:
, :

( -40-
~'7~
To a mixture o~ 25 ml of ethyl acetate and lO
ml of water was added 800 mg (0.00261 mole) of BL~P201
potassium salt. After all of the solicl had dissolved,
the mixture was treated dropwise with 50~ aqueous phosphoric
acid with vigorous shalsing until no more material precipitated
~rom the aqueous layer. me ethyl acetate layer was
separated, then washed with s~tuated sodium chloride ~olution
and dried over ~ drou~ magneslum sul~ate. me drying agent
was removed by filtra~ion and washed with lO ml of eth~l
acetate. (The wash solvent was combined with the original
filtrate). "Skellysolve B" was then added to the ethyl
acetate to ~he cloud po~nt (approx. lO ml). The mlxture
wa~ treated with 500 mg of acti~ated carbon ("Darko KB")
and filtered. The ~lltrate was diluted w~th 15 ml of
"Skellysolve ~", then seeded with crystals o~ BL-P2013
free ~cid. Af~er approx~ 3 hours at room temperature, the
crystalline precipitate of ~ree acid was collected and
dried: in vacuo (15 min) over P~05 to obta~ 323 mg (46~)
mOp. slow decomp. over 100.
Anal. ~ Calcd, for C8~1oClN~ S: C~ ~5.89, H, ~.~7; ~"5~23,
. 5 . .
C1, 13.2S
Found: C, 35.88, H, ~5.91~ Ng 5.41; Cl, 1~.52
This product was Pound to be unstable when stored
at 2~C. ~or even days.
*Trademark

7~ g
Example 15
6a-Bromopenicillanic Acid Sulfoxide
_ O
Br"" ~ S Br" r S
(C6H5C~2NXCH2)2 ~
02E ' C0 H
MW 800.64 MW 296.14
To ~ 1 of methylene chloride w s added ~00 g
(0.7~ mole) of 6a-bromopenicillanic acid N,N'-dibenzyl-
ethylenediamine salt and this suspension was cooled to
5. Then over a 15 min. period, with good stirring, 130
ml of conc. HCl was added dropwise. The slurry was
stirred at 5c for 2 hours~ It was then filtered through
a ("Celite") pad of diatomaceous earth and the cake was
washed with 3 x 250 ml of methylene chloride.
The c~mb~ned methylene chloride solutions were
washed with 2 x 500 ml H20 and dried over sodium sulfate
for 15 mln. The sodium sul~ate was removed by filtration
and the ~iltrate evaporated under reduced pressure to approx.
750 ~1.
This æolution was cooled to 5 and, with vigorous
stirring, 130 ml of 40~ peracetic acid was added dropwise
such that the temperature was maintained at 5 to 12.
me addition was quite exothermic. At the end o~ the addition,
the slurry wa~ st~rred at 5 ~or 2 hours and the product
collected by filtration a~d washed with 100 ml of cold H20
(5) and 100 ml of cold methylene chlorlde (5). There
was obtained 126 g (57%) o~ 6a-bromope~icillanic acid
sulfoxide, m.p. 129. me ir and nmr spectra were consis~ent
for the desired product.
Anal. Calcd. for C8HlQBr~04S: C, 32~44, H, 3.40; ~, 4.7~.
.. . . .
F~un~: C, 32~3~; H, 3u~5; ~, 4.71
H20, 2.18.
: ,

( -42-
Potassium 6a~Bromopenieillanate Sulfoxide
O O
CO2H ~2K
.MW ~.24
To 3 1 of acetone was added 126 g (0.4~ mole)
of 6a-bromopenicillanic acid sulfoxide and 162 ml of 50%
by weight potasslum 2-ethylhexanoir acid in n-butanol.
After stirring 1 hour at 22, the product was collected
by filtration, washed with 2 ~ 250 ml of acetone and dried.
ere was obtained 127 g (90%) of potassium 6a-bromo-
penicillanate sul~oxide, m.p. 185. m e ir and nmr spectra
were consistent ~or the desired structure.
Anal. Calcd. for C8 ~ BrKN04S: C3 28.7~; X~ 2.71; N~ 4.19.
- Found: C, 29.03; H, 2.7~; N, 4.0~.
:,~
'

4 3 ~
a~8~9
p-Nitrobenzyl 6a-Bromo~en-icillanate Sulf oxide
O O
Br ~ 1~
C2K ~ 2 C~I~No2
MW ~31.28
To 1 1 of N,N-dimethylacetamide w~ added 145
g (0.43 mole) pot~ssiuQn 6a-bromopenicillanate sulfoxide~
and, with ~tirring, there w~s then addPd 115 g (0.5~ mole)
o~ p-nitrobenzyl bromide at 22~. The mixture was stirred
at 22 for 20 hours.
The reaction mixture was poured into ~ 1 o~ E20
and e~ctracted with ~ x 1500 ml of ethyl acetate. The
combined ethyl acetate extracts were washed with 2 x 500
ml of 5% aqueous sodium bicarbonate solut on and dried
o~er sodium sulfate ~or 1/2 hour. The sodlum sulfate was
~iltered o~f and the filtrate e~aporated under reduced
pressure to a residue to which 1 1 of diethyl ether was
added causing the product to crystallize. The crystals
were collected by ~iltration, washed with 2 x 100 ml o~
diethyl ether and dried to yield 162 g ~87~) o~ p nltro-
benzyl 6a-bromopenicillanate sul~oxide, m.p. 111. The
ir and nmr spectra were con~istent ~or the de~ired structure.
_ or C15H16Br~20~S: C, 41.78; H, 3-51; N 6 50
Foun~: C, 41.66; H, 3045; N, 6.85;
H20, o.69.

--44--
:~7~
~-carboxvlate
v
~C02CII~ Br,~ N2
~W 449,71
To 1 1 of p-dioxane was added to 70 g (O. 16
mole ) of p-nitrobenzyl . 6a-bromopenicillanate sulfoxide
followed by 21.2 ml (0.10 mole) of' benzoyl chloride and
21.8 ml ~0.19 mole) o~ quinoline. The reaction mixture
was reflwced for 4 ho-ars and then cooled to 22, poured
into 2500 ml of ~I20 and extracted into 3 x 800 ml of
ethyl acetate. The c~mbined ethyl acetate extracts were
washed w~ 300 ml of ~% aqueous sodium bicarbonate
solutior~, 300 ml o~ 5% aqueous pho~phoric ~c1a-an~ ~00
ml o~ ~0. The ethyl acet~te solution was dried over
sodium sul~ate for l/2 hour and the sodium sul~ate was
removed b~ filtration. The ~iltrate w~s evaporated
under reduced pres~ure to a re~idue which was redissolved
in 1 1. of eth~l acetate and again evapora~ed under reduced
pressure to a resldue. m en 1 1. o~ diethyl ether was
added and the product collected by ~iltration to yield
41 g (57%) o~ p nitrobenzyl 6a-bromo-2~-chloromethyl-2-
methylpen~m-~-carboxylate, m.p. 1~2. The ir and nmr
spectra were consis tent for the desired structure.
r C15H14BrClN205S: C, 40 . o6; H, 3-14; N 6 23
Found: C, 40.62; H, 3.11; N, 6.13.

( -~5-
S~
p-Nitrobenz~l 6a-Bromo-2~-chloromet~ 2-methylpenam-3-
carboxylate Sulfoxide
.. _ . ~ . . O
13r~S~N32Cl r~S JC cl
i N ~" N - ~,
. N2 MW 465.71 ~ N02
To 1200 ml of methylPne chloride was addecl 51 g
(0.11 mole) of p-nitrobenzyl 6a-bromo-2~-chloromethyl-2-
methlypenam-~-carboxylate ~ollowed by 23 ~ (0.12 mole) of
m-chIorop.eroxybenæoic ac~d. The solutlon was stirred at
22 ~or 2 hours and evaporated under reduced pressure to a
wet residue. m e residue was stirred with 4 1 of diethyl
ether ~or 1 hour and a~lowed to stand at 10 for 20 hours.
The product crystallized out and was collected by ~iltra~ion,
washed wlth 2 ~ 200 ml of diethyl ether and dried, yielding
~9 g p-nitrobenzyl 6a-bro~o-2~-chloromethyl-2-methyl~enam-3-
car~o~ylate sulfoxlde (75%)~ m.p. 1~2~. m e ir and nmr
sp~ctra were consistent for the desired structure.
Anal Calcd. ~or C15~14BrClN206S: , ~
. Found: C, ~&.98; H, 3.04; N, 5.84;
0, -35~

( 46-
Potassium ?~hlorometh~
. 5~1fone (BL-P201
; . - . . _ . . _ . .
O O
C 2 ___~ c~3
N - ~" r-~ N
(~02CH~ N2 $`CQ2K
BL-P2013
M ~05.77 _ _
.
To 600 ml of H?0 ~as added 8 g o~ 30% Pd on
"Celite" and 16 g (0.19 mole) o~ sodium bicarbonate.
Then 32 g (o.69 mole) of p-nitrobenzyl 6a-bromo-2~-
chloromethyl~2-methylpenam-~-carboxylate sul~ox~de was
dissolved in ~00 ml ~f ethyl acetate and added to the
aqueous slurry. me mlxture was hydrogenated on a Paar
appaxatus at 50 p.s.i. at 22 ~or 4 hours. The slurry
was filtered through a thin "Cellte" pad cn a sintered
glass funnel, the p~d was washed ~ith 2 x 50 ml H 0 and
the aqueous layer of the combi~ed filtrate and wash~lgs
was separated~ me aqueous layer was washed with 200 ml
of diethyl ether, then was cooled to 5~ and, with sti.rring,
a solutlon of 12 g. (.076 mole) of KMnO4 in 200 ml o~` ~0
was added dropwise over a 1/2 hour period, keep~ng the pH
between 7..5 ~nd 8.o by the addition o~ 40%.~P04. When
the pink color persisted ~or 5 minute~ no more KMnO4
solution was added. rhe reaction mixture was stirred
wlth a small amcun~ (approx. 50 mg) of sodium b~sulflte ~or
1/2 hour, and then the slurry was ~lltered through ~ "Celite"
pad. The pad ~as washed with 2 x 50 ml of ~ 0. The
.

~47- .
combined ~iltrate and washing~ wërP layered with 500 ml of
ethyl acetate and, with stirring, the pH was adjusted to
1.5 by the addi.tion o~ 2 N HCl. The layers were ~eparated
and the aqueous layer was saturated w~th sodium sulfate~
It was reextracted with 2 x 400 ml of ethyl acetate and the
. .
combined ethyl acetate e~tractæ were drL~d over sodium
sul~ate ~or 1/2 hour ~t 5. The sodium ~ulfate was
removed b~ filtration and the ~iltrate evaporated under
reduced pressure to a residue. That residue was dissolved
in 1~0 ml o~ acetone and 160 ml of diethyl ether and 50%
by weight of potassium 2-RthyIhe~anoate in n-butanol
~as added until the solution ~as neutral to moist pH paper.
me potassium s lt o~ BL-P2013 crystalli~ed out, w~s
collected b~ filtration, washed with diethyl ether and
dried. Yield 16 g potassium 2~chloromethyl-2-methylpen~m-
3-carboxylate ~ulfone (BL-P2013) ~76%), m.p. 202. ~he
ir and nmr spectra were consistent ~or the desired structure.
Ar~ ~. Calcd. for C8H~ClKN05S: C, ~1.42; H, 2.97; N, ~.58.
Fo~n~: C, 31.18, H5 2.98; N3 4.51;
._ . .. - . - H203 0.93.
,~
'
'.
.~ .

--Z~ 8-- !
Example 16
~ =_
carbox~late Sul~one (Bl-P2024)
- O O O O
~S~ C~ Cl ~ C1
~,eH~ _ > ~'~"CE~3
C02K ~ C02CH~OCOc (cH~j )3
B~P2024
-_ _ MW ~81.8
_ . ~
To a stirred suspension of 14.6 g (o.0487 mole)
of potasæium 2~-chlor~methyl-2-methylpen~m-~carboxylate
sul~one (BL-P2013~ in 200 ml of acetone was add~d 4 ml of
a 10% aqueous solution o~ sodium iodide and the mixture
was brought to re~lux on the steam bath~ To this reflux
ing suspension was added 1~.8 ml. (0.1 mole) of redistilled
chloromethyl pi~alate (bp ~4CC ~t 7 mm Hg) all at o~ce.
The mixture was stirred at reflux for three hours and then
cooled to room temperature (22 C). The cry~talline solids
were collected by.filtration, washed with 3 x ~0 ml o~
a~etone a~d the combined :~lltrates were evaporated to an
oil under reduced pressure at ~22~ C. The oll wa~ then
taken up :ln 500 ml Qf ethyl acetate and washed once with
water (200 ml) and once with 3aturated Na2S0~ ~olutlon
(200 ml). The solution was then dried briePly over ~a2S04
whlle being stirred with Z g o~ de~oloriz~ng carbon with
cooling (lce bath). A~ter 20 mln. the m~xture was ~iltered
through a "Cel~te" pad Qnd the pad washed with 4 x 100 ml
o~ ~thyl acetate~ The comb~ned filtrates were concentrated
under reduced pre~sure at 22 C to an oil. The oil wa~
then further concentrated at about 22 C ~nd <1 mm ~g to
remov~ most of the res~dual chloromethyl pivalate. The
remaining oil was then trlturA~ed twice w~th 50 ml port~ons
of n-pentane and then left over the weekend ~t about 10 C
:

--49--
under n~pentane. me resulting solid cr~stalline mass
was then broken up to a powder under 40 ml of a 4:1
mixture o~ diethyl ether-n-pentane. The product was
then collected by filtration, washed with diethyl ether-
npentane (1:1) then n-pentane and air dried. A~ter
drying under high vacuum ~or four hours over P205 thare
was obtained 13.37 g pi~aloylox~methyl 2~-chlorometh~l-
2-methylpen~m-3-carbo~ylate.sul~one (BL-P2024) about; (75%)~
m.p. ~3 - 9~ C
:
:
.

-50-
Puri~cation o~ ~L-P2OZ4
Approx~m~tely 3 g. o~ crude BL-P2024 ~obtalnad
as described abo~e) w~s d~s~olved in 5 ml, of ethyl
acetate, placed on a 4.5 x 40 cm, column of silica gel
(Mallinckrodt CC-7), and eluted w~th ~ v C ~ Cl2-
ethyl acetate. The ~ractions containing a s~ngle spot
at RfO.8~ (TIC o~ æilica gel plates with 4:1 C~2Cl2-
ethyl acetate, I2 detectlon) were combined and concentra-
ted under reduced pressure to 1.38 g. of a ~rys~alline
solid. A portion of this materlal (900 mg.) was dis-
solved in 5 ml. of ethyl acetate; the resulting solution
was ~iltered, diluted ~lmost to the cloud point with
petrole~m ether ("Skellysol~e ~") and then store~ at room
temperature ~or three days. The crystals which fo ~ ed
were collected by filtr~tion, washed with petrole~m ether
and dried ~o give 560 mg., m.p. 100-101., o~ purified
BL-P2024,
Anal.~Calcd. ~or C14 ~ oCl~O~S: C, 44.03; ~, 5.27; N, 3.67
- Found: C, 44.11; E, 5.o8; N, ~.85.
All t~mperatures in this application ar0 given
ln degrèes Centlgrade.
...

39
--51--
Prepar~tion ofi BL-P2013 Ammo~ium Salt
1. The free acid of BL-P2013 (250 mg. ) dissolved in 20
ml. of acetolle-me~hanol (1:1 by volume) was filtered to get
~ clear solution.
2. Anhydrous ammoniu~h solution was prepared by adding 1 ml.
of ammorlium hydroxide (307~" reagent grade) to 10 ml~ of
acetone-methanol (1:1 by volume3 solvent and then 1 gm.
of anhydrous magnesium sulfate was added to that solution
with mild agitation and the mixture was filtered thrQugh
a ~ilter paper; the ~iltrate was designated "anhydrous
ammonillm solution. "
3. To the ~lltrate of Procedure 19 approximatel~ 2 ml. o~
"arihydrous aanmonium solutio~" was gradually added and mixed
well.
4. A 100 ml, portion of diethyl ether was mixed with the
mixture from Procedure 5 to precipitate the a;mmonium salt
o~ 13L-P2013.
5. ~he white ~Lmmoni~am salt was iso}at0d from the sol~rent
ànd washed with 2 portions of 50 ml. each o~ diethyl ether.
60 me isolated powder ~as dried at 55 C vacuum o-ren for
overnight .,
7. Analytical data were as ~ollows:
Calculated ~ C 5~5.7; 4.6; N 9.8;
Found C ~5~i.66; H 4.63; ~ 10.12; dry by KF
Micro~coplc Examlnation: crgstalline ~ubstance

--5 2-- ~ !
Ex~ple 18
Preparation of Non-hy~roscopic Sodium Salt o~ Bl-P201~
1. Dissolve 50 mg. of the free acid of ~L-P201~ i~ 4 ml.
of acetone-methanol (1:1 by rolume) mixture. Filter to
get a clear solutlon.
2. Prep~-re sodium 2-ethylhexanoate solution b~ dissol~ing
40 mg. of sodium 2-ethyIhexanoate ln 10 ml. o~ acetone-
methanol (1:1 by volume) mixture.
. To the ~ltrate of Yrocedure 15 ~dd the 10 ml. solution
o~ Procedure 2 ~nd mix well.
. A 10 ml. portion o~ diethyl ether was mixed with the
mixture from Pro~edure ~ to precipit~te ~he sodium salt of
BL-P201~.
5. The white salt was ~mmersed in the diethyl ether ~or
1-2 hours and th~n was isolated from the ~olvent and washed
with 3 portions of 5 ml. each of dlethyl ether.
6. The isol~ted powder was dried at 30 C vacuum oven
rOr overnlght~ :
:

--53-- ~ ~
~s~
O O ~) O
~ S~ CH2Cl Recryst . \\~ C~I2G1
_~_ ~ f ~, ~
~' CE~; H20-acetone ~ ~CE3
"' C02E~I20 ~ C2 2
BI~P2013 (400 mg. ) w~s dissol~ed in a min~num amount of
acetone~H20 (l:I) by volume and diluted with 10 ml. o~
acetone, :eiltered, then diluted with ac~tone to abalt
25 ml., ~cratched, and a~ter ~iO minutes t~e cryst~llirle
hydrate was collected by filtration~ washed well with
acetone, air dried and: then ~acuum dried at ~1 mm. H~
overnight.
Yield 280 mg.
Anal. Calcd~. ~or C8HgClNQSK~ H20: C, 29~67; H, ~.~9; 1~, 4.63;
... . : Cl, 10.94; ~I20, 5~55.
Found: C., 9. ~:2; H, ~,32, N, 4.44;
C1, 11.31, H~0, 5.90.

i -54-
~e~
~ N'-Dibenzylethylenediamine S~lt.of BL-P201~
_...
BL-P2013 + 1/2 NgN~-Dibenzylethylenedi~m~nc diacetate
~. ~
Recryst.~ / 0~ ~/a C ~ Cl \ .
Aceto~e-ether ~ ~ C ~ ~
~ ' C 02H C6H5CH2N~-CH2t
\ / 2
306 mg. (0.001 ml) of BL-P201~ was dissolved
in 7 ml. H20 and added to solution o~ 180 mg. (0.000~ mol)
o~ N~N'-dibenzylethylenediamlne diacetat~ in 7 ml. H20.
The mixture was stirred and the alt crystallized ~nd after
stirring approximately 1~-15 minute~ the salt was collected
by ~iltration and air dried to yield N,N'-dibenzylethylene-
di~mine salt of BL-P201~ (~00 mg). The material was re-
crystallized b~ dis~olving it in approximately 10 mln 0~
boiling acetone and dilutlng with ether to the cloud point.
260 m~. o~ air ~ried and vacuum dried material was obtained~
Anal. C lcd: C~ 51.69; H, 5.42~ N, 7.5~; Cl, 9.55.
Found: C, 49.39; H~ 5.49; NJ 7.05; C1~ 8.96;
~2' 1.23 (KF).

( --55-- )
~7ASF~C99t
Example 21
Chloromethyl E~ter of BL-P2013
.. ... . . .
- .. . .
O O
CH2Cl + ClCH2-0 S02Cl
~CF~ + (CH3cH2cx2cH2)~ ~fIso4
0~ ~COOK ~ 3 KXC03
(:~5 7)
~ CH2C12
1 H20
-
O O
~ r~Cl
.
C/-ocN
(316 -17)
,.. .. . ... .. . . .... . .

?
-56-
To ~ vigorously stirred m~xtu:re of 15.25 g(0.0~ mol) of BL-P2013 (53, 15 ~. (0.15 mol) KHC0~ and 1.7
g (0.005 mol) of tetrabutyl~mmonium hydrogen sulfate
(Aldrich Chem. Co.) ln a mixture o~ 50 ml. water ~nd
50 ml. CH2C12 there was added dropwise a solutlon o~ 9.5
g (0.0575 mol) of ClC ~ -0-S02Cl in 40 ml. CE2C12. me
temperature rose to 26 C. and after the addition ~w~ich
took about 15 minutes) the m~xture w~s stirred another ~0
inuteæ. Beca~se the product cr~stallized out more CH~C12
tabout 400 ml.) was addPd to obtain a solution. me
separated CH2C12 layer and a 50 ml. C ~ C12 wash were com-
bined, dried over MgS0~ with stirrlng and 2 g o~ decoloriz-
ing carb~n ("Darco KB") was added. After about ~0 minutes
the mixture was ~ltered, concentrated to a~out 50 ~1. and
isopropyl alcohol (15~ ml.) was added. The rest of the
CH2C12 was then removed under reduced pressure. Th~
resulting crystalline precipitate Wa8 col~ected by filtra-
tio~, washed well with isopropyl alcohol and air-dried.
A~t~r vacuum drying at lesæ than 1 mm. Hg there was obtained
8.5 g o~ chloromethyl 2~-chloromethyl-2-methylpenam-3-
carboxylate sulfone (1). M.p. 116 (decO~ darkens above 100C~.
Anal. Calcd. ~or CgHl~C12~0~S: Cg 34.18~ HJ 3.51; N~ 4.43;
Cl, ~2.43.
Found: C~ 34.16; H, ~.45; N, 4.47;
~ Cl, 2~ ~6, ~ 0~ 0-33 (KF)-
Estimated purity i~ the 90-95~ range.

I -57-
Iodomethyl Ester of 3L- 2013
\S ~ CH2Cl Na I ~"
r~ I CH~ CH3
0 ~ C-ocH2cl 8 C-0C~2I
To a stirred mixture of 5 g. (0.0159 mol) of
~the chlor~methyl ester of BL-P201~ (7) in 25 ml. acetone
was added 3 g. (0.02 mol) of sod1um iodide. m e resulting
~lurry was stirred for 17 houræ and then cooled to about
OC. Two drops of saturated a~ueous KHC03 were added
and the mixture was slowly diluted dropwise with water
over ten minutes until 50 ml. had been added. m e
; slurry underwent a sudden color change from yellow to
grey to purple to black and therefore the crystals were
immediately collected by filtration and w~shed with cold
acetone-water (1:2) and then isopropyl alcohol (~ x 10 ml)~
then dieth~l ether and finally n-pentane and air-dried
to yield 5.5~ g. (91~ yield) of the iodomethyl ester of
BL-P201~ (8). M.p. 118 - 119C. with decomposition.
Purity estlmated at about 90%.
~ . , .
6-~ 5R?-2-~lno-2-phenylaceta~ido]-3,3-dimethyl-7-oxo-4-
thia-l-azabicycloC ~ . 2 . 0~ heptane-Z-c arbonyloxymethyl
2~-chloromethyl-2-a-methylpenam-~a-carboxylate sulfone (11)
_, .

--~8-- ~)
8~ C~CoN~ ~5~CR3
H~C ~ N
H C~ ,~0
~:~C ~A Dane ~alt of ~mpic~llin; see U.S.
H~ Patent 3,~6,247)
~~
H~C--C H
I
OC~I3 0
lo J , ~_
. o
¦E
.
:~
.

. -59-
~C~--CO~
O
~ 2
~--O
: O
~:
To a stirred mixture cooIed ~n an ice-bath of
~.46 g. (0.01 mol) of the indicated Dane salt of ampicillin
; ~ (which was solvated with one molecule o~ propyl
alcohol) in 60 ml. acetone there was added 4~o8 g. (0,01 ml)
~: : of th2 iodomethyl ester of BI-P201~ (8) and the resulting
nearly clear ~olu^tion was stirred ~or fi~e hours with the
ice-bath removed ~fter 30 minutes. m en most o~ the acetone
was removed in vacuum on the roto-vap and the resulting
concentrated solution was dis~olved in 2~0 ml. cold ethyl
aceta~e which was then washed wit~ 2 x 50 ml. ice cold water
and 2 x 100 ml. saturated a~ueous Na2SO~. The ethyl acetate
solution was then dried over Na2S04, flltered and most of
the ethyl acetate wa~ removed in vacuo on the roto-vap.
The residue wa~ tr~turated wtth 2 x 200 ml. dry diethyl
ether and the resulting solids were collected by filtration
to gi~e 5.5 e. o~ lo as a plnkish powder. This powder was
,

--6 0 ~
stirred ~n a m~xture of 50 ml. water, 50 ml. n-butanol
and 20 ml. ethyl acetate while 6N HCl was added dropwise
to pH 2 . 5 . Then occasionally a drop or two of HCl was
added to keep the p~ at 2 . 2 - 2 . ~ over 45 minutes . When
the pH no longer drifted upward there was added to this
mixture 100 ml. diethyl ether with good stirring. The
aqueous phase was separated and combined with a seeorld
25 ml. H20 extract of the organic layer The aqueous
solution was extracted once with 50 ml. diethyl ether
and the ether was discarded.
me ~queous layer was then stirred vigorously
under a layer o~ 100 ml 2-butanone (methyl ethyl }~etone)
while Na2S04 was added to saturate the aqueous layer. Ihe
2 butanone layer was separated, dried over ~a~,S04
for ~0 minutes in an ice-bath, :~iltered and concentrated
in ~acuo to near dryness. The residual oil was triturated
to a solid with n-butanol, wa~hed well with ether, then
n-pentane, air-dried and then Yacuum-dried over P20~; at
<1 mm Hg pressure to yield 1.6 g. 6-~ (R)-2-amlno-2-pbenylace-
tamido]-~,3-d~methyl-7-oxo-4-thia-1-azabicyclor3.2.0}heptane-2-
carbonylmethyl 2~-chloromethyl--2-a-methylpenam-3a-carboxylate
sulfone (11) in crude fo~n. The IR and nmr spectra were
consistent with structure 11 but not with high purity.
This solid product was estimated to contain at least
40% and perhaps as much as 80% 6-~ (R)-2-a:mino-2-phenylace-
tamido] 3~3~dimethyl-7-oxo-4 -th~ a-l-azabicyc lo~ ~ . 2~0]
heptane-2-carbonyloxymethyl 2~-chloromethyl-2-a-methyl-
penam-3a-carboxyla~e sulro~e.

~ -61-
Improved Synthesis o~ BL-P2013
This procedure simplifies production of
BL-P2013 by eliminating the previous use o~ cakalytic
reduction.
St~p
Br,
4 CH~CC~ + Dicyclohexylcarbodiimide
1 Pyrid~ne
C~C12
O
Br~ ~ 2
O C-OCH2CC~
O
(See page 63~ of Cephalosporins and Penicillins, edlted by
Edwin H. Flynn, Academlc Pres~, New York, 197 )
6a-Bromopenicillanlc acid sulfoxide (1) (30 ~.
0.1 mol) ~a~ dissolved ln 1 1. dry C ~ Cl~ ~ollowed by
the addition of 16.2 ml. (0.~ mol) p~ridine and 29.8 g.
(0.2 mol) trichloroethanol. Then 20 g. (0.1 mol) of
dicyclohexylcarbodiimide wa~ ~dded and the mixture was
stirred at 22 for 16 hours. Dlcyclohexylurea began
,

( -62- .
to precipitate out, at the end it was removed by ~iltration.
The filtrate wa~ washed with 200 ml. o~ 5% ~queous ~odium
bicarbonate3 200 ml. of 10~ phosphoric acid and 100 ml.
o~ saturated aqueous sodium sulfate. The organic phase was
dried over sodium sulfate at 5C. ~or 30 minutes, ~iltered
and evaporated to an oil. Diethyl ether was added and,
with scratching, the product 2 cry~tallized out (27 g.,
63% yield).
Step 2
2 1 ~ 0
- ~CCl
Quinoline
CC1
o ~ C- OCH2~C13
o
C~mpound 2 (26.5 g.~ 0.062 mol~ wa8 dissolved in
500 ml. p-dioxane and there was added 8.5 ml. (o.o78 mole)
ben~oyl chlorlde ~nd 8.75 ml. (o.o78 mole) quinoline. The
solution was re~luxed for four hour~ and then poured ~nto
1100 ml. water and the product ~ w~s extracted into
~ x 400 ml. ethyl acetate. q~he ethyl acetate extracts
w~re combined, succes~i~re~y washed with 200 ml. 5%
aqueous sodium b~carbonate, 200 ml. 5% phosphoric acid
and 200 ml. saturated aqueous sodium. sul~ate, dried over
sodlum sulrate at 5C. for th$rty m~utes and evaporated
to an oil (~,) which was used l'a~ ls " for the next reactlon.

( -63- ~
L~7be~
; Step
~S ~0~ H202
in glaciPl
acPtic acid
~ /
Q V
'F3~C 2C
O C-OCH2CCl~
;; :
Compound ~ obta~ned ~n the pre~iou~ step was
: dissolv~d ln 1 1. glacial acetic acid and, with st~rring
at 22Cog a saturated a~ueou~ solut~on o~ KMhO4 was
added dropwise until a pink color persisted ~that is,
a drop placed on a plece o~ filter paper ga~e a pink
coloration). Then with cooling ~~ ~2 wa3 added
dropw$se until a clear solution was obtained; some
white precipitate was pre~ent. me solution was
poured into 2.5 1. water and the product 4 was extracted
into 3 x 500 ml. eth~yl acetate. The ethyl acetate was
wa~hed with 5~t aqueous sod$um b~c~rbonate until neutral
(that is, no more bubbling upon additlox~)g dried o~rer
sod$um sul~ate a~d ev~porated to iea~e 4 as the residue.

-64-
~ ~7 ~
It was le~t ~t 10C. ~or one day and then triturated
with "Skellysol~e B" to yield 9.1 g. solid 4. me
yield was 28~ of theory for ~teps 2 and 3 comblned.
St~p ~
4 + ~ Zn in Acetic Acid
KEH
~ CH Cl
C~ 5 (BL-P201~)
~ N~
o COOK
(See U. SJ Patent 4,164,497)
Zlnc dust (3.7~ g.) was slur~ied in 5 ml. glacial
acetic acid and cooled to 5C. To thi~ ~xture th~r~ was
added a solution of 4 (~ g.; 0.0057 mol~) in 15 ml.
dlmet~ylfo~mamide and the resulting slurry was stirred
at 5 ~or 2.5 hours.
m e zinc wa~ then ~iltered o~ and the pale
~ellow solutlon was poured into 80 ml. o~ 5% aqueou~
hydrochloric acid. That mixture was extracted with ~ x 25
ml. ethyl acetate. The c~mbined ethyl acetate extracts were
e~tracted wlth ~ x 20 ml. o~ 5~ aqueous sodium bicarbonate,
savi~g the ethyl acetate phase a~ter separation.

7~
-65-
me bicarbon~te extracts were combined, placed
under a layer o~ ethyl acetate~ ad~usted to pH 1.5 by
the addition of 2N HCl and ~aturated with sodium sulfate.
The ethyl acetate was separated and the aqueous phase
was extracted with 2 x ~0 ml. ethyl acet~te.
All of the ethyl acetate pha es above were
combined, dried over sodium sulfate and evaporat~d to an
oil (which was the ~ree acid fo~m of BL-P2013) which was
dissolved in about 20 ml. acetone to which 20 ml. die~h~l
ether was then added. Then 50% potassium 2-ethylhe~anoate
(KEH) in d~y n-butanol was added to neu-tralit~. The
product 5 ~BI-P2013~ crystalllzed out. After stirring
0.5 hour at 22 it was collected by flltration to yield
650 mgm. of 5 (~7% yi~ld).
A 50 mgm. sample of 5 was di~sol~ed in 0.5 ml.
water and 20 mgm. N~N'-dibenzylethylenediamine (D~ED)
~iacetate was added. The DBED salt of 5 crystallized out,
was collected by filtration~ w~shed with water and dried
over P205 under ~acuum to yield ~,NI-dibenzylethylenedi~mine
2~-chloro~ethyl-2-methylpenam-3-carboxylate sul~one (DBED
salt of ~ree acid 5).
Another sample o~ 5 (450 mgm.) was dis~ol~ed ln
3 ml. water to which wa~ added ~ solution o~ 270 m~m. DBED
d~acetate ~n 2 nLL. ~ 0. With scratching the DBED sa:Lt of
~ crystalllzed out (4~0 mgm.). Recrystallization from
about 5 ml. boiling acetone yielded 270 mgm.

~cam~e 2 ~i
6_~ (R) -2-Amino- -p-hydroxyphenylacetamido~ dimethyl-7-
oxo~4-thia-1 ~z~bicycloE3.2.0]hep ane-2-carb~nyl~ee~uq
2~chloromethyl-2-a-methyll?enam-3a-carboxylate sulfone
_ _ _ __ _ ___ _
having the f o~mula
N~2 o/~'C~13
' .
.
1~ produced by substitutixlg the corresponding D~ne ~alt o~
amoxlciilin ~or the ampicillin used in the procedure of
Example 21.

\~
BIOLOGICAL DATA
~ he product o~ aple 1~ Compound 5 , having
the structure
~H;2Cl : :
r~ C~3
,~ N g
C02B
will ~e reerred t~ below as sL-p2ol3
~;
Alt~iough at best a Yery ~eak a~ibacterial age~t
i~self, BL-P2013 inhibits ~-lactamases and pro~et:ted
ceforanide and amoxicillin from destruction by ~-lactama~e-
: ~ producing ~acteria in vi~ro ~nd irl vi~o . when usedcombination with thoRe two age~ts,
:; : :
.
~: :
.. .
, ~ ,

--68--
Table 1
~tibacterial Activity of th~ _ 6~-lfone
_~ ~
Organism
BL--P2 013 ~npicill~
~_
....... ~ :
. pneumoniae A-9585 16 0 . 004
~- .
04 63 0. 00
15- aureusA-9537
5. Olre~ '
5Q% sen~m A-9537 ~125 O. ~6
D. ~lr~
~es A-9606 ~125 ~125
S. aureus Meth- __ _
Res A15097 >125 125
S.. faecalis A20688 >125 0~13
E. coii ~A15119 ~125 ~ 1
Eo coli A20341-1
R. pne~mon~aeA15130~ ~125 ~ 125
K. pneumoniaeA2 04 68 >12 5 ~12 5
i~~ ~ A- 9 90 0 > 12 5 0 ~13
. ~ ._ . . . . ._ _
P. ~rulgari~;A21559 >125 125
P . Iw rganliI~l ~isi _
P. rettgeri~21203 ~12 5 . __ 4_ _ ¦
S~ marcescensA20019 >125 16:
. _ ~ . ~
E. cloacaeA-9659 ~125 63
Eo cloacaeA-9656 ~lZ 5 , '
P. aerug~nosaA-9843A ~125 >125
P,.aerllgirlosa A21213 > 125 ~1;25

_~9_ )
~'7~
Tabl e 2
Bacteroides ~cti~rity of Ceforanide and Amoxicil lin
Alone and in Combination with ~IL-P2 013
.
_ _ Eleta- ~
Organism lact- ~ Ce~o-CeforanideAmoxicilliI~ Amoaci-
. amas~ ranide ~L-P2013;~oL13 +B~-2013cilli~
~ _,
B a fragiIis
A2191 l 63 2 ~125 Z 8
~: ~22~53 ~ 32 ~q 63 2 8
AZ202 + 32 2 32 _2_ 4
A2187 ~ 32 4 63 2 8
A2253 ~ >125 32 125 16 >125
A2269 ~ 63 8 63 2 8
A2269 ~ 63 4 63 2 16
A22694 ~ 125 16 . 63 2 16
A2269 ~ ~125 _16_ 3Z 4 125
::: ~2~69 + >125 _3~ 63 8 ~125
A2253 ~ ~125 _32 32 32 ~125
:: A2253 + ~125 32 125 32 ~125
A2279 ~ >125 ~ 32 4 125
A227 9 + 32 4 32 2 8
A2279 ~ 32 4 32 2 8
~79 ~ ~3 ~ 32 ~ 16
A2279 + 63 4 63 2 16
~2279 .~ 3~ ~ 63 2 8
3. theta-
iotaomic- .
r~n A2227 + 125 4 63 2 16
A2227 + 125 8 63 q 16
. .~ ~ ,
",~ :

--70--
~7~
Table 2 - cont ' d .
Anti-Bac:teroides Activity of Ceforanide and A~noxicillin
~ _ .
Alone a~d in Combination with BL-P2013
. . Beta-
Organism lact- _
amas ranide I BL-P20132013 ~BL-P2013cillin
_ ~ _ ~
acteroides
pecies
A2093 ~ 32 4 32 2 8
A21gS + 63 ~ 4 32 2 16
~2092 ~ 63 4 32 2 16
A2195 ~ 6~ 16 63 2 16
A20~3 ~ 63 16 63 ~
~2093 ~ 125 ~ 125 4 32
: ~~2093 + 63 ~ 32 2 1~
' 1~20927- _ 0,5 1 63 ~.13 0.13
A2093' _ 2 2 125 0 ,131~ .13
::
--good synergism
--- marginal ~ynergi~m
*Minimum inhibitory concentration ~MIIC~ dete~mined by the
agar dilution method using SOX dilution~ o 2 4 hour cultures
Z!~5 inocula dispensed by the 5teer ' ~ inoculatorO Assay
~editDn composed of Brucella Agar plu~ 5~ laked ~heep blood
and 10 mcg/ml vitamin XO
. . .
: , ,

--71-- )
7SI~
Table 3
Therapeutic Efficacy of Amoxicillin in Combination with
Lac:tamase Strain of StaphYlococcus aureus
~ ' .
~: ~ Challenge ~
Orgarlism t:)rganisms) = IM PO
: . . . ~ .
~: S. aureus S x 108 >800 ~8Q0: ¦ ~50 ~200 6.3 44
~; ~A 9506 5 x 108 >800 ~800 ¦ ~sn ~200 19 77
7 x 10~ ~ _
Treatment schedule: Drugs ad~i~inistered 0 and 2 hours post-
ectic~nO . :'
: ;

-72~ S~
. . __ ~ .
s~ ~n ~
~ o~ ~ ~ ~ ,~
ra_I ~ 1 0 O ~ O
11~ ~ ~ O ~ a~ D
a~ ~ o~o~ g~
D- .. 1. I . I . ~ . ~ o I
O E3 ~ ~
. .- ,~
I ~ o I o o o ~
4~ _I ~ 2
. ~-rJ .
_ ,. -. , , ... ~W ~.; . .
.
~J O ~ D~ M 3
I~tl ~o o . ~ ' o
&3 _I O N~ o~ N
O
0 ~ ~ ~ In ~ U~ 1 CO
~3 ~ ~i N~ It~ ~
;" a~ ._ ~ v ~n
X C) ~ 0
:~ ~ ~ ~ ~ -
o ~ . . . . . ..
~ o ~ o~ ~a ~ ~ ~ 5` ~ a~ ~
r~l ~ ~ ,~¢ V O
~ ~ _l ~ ~
p~ O ~ O ~ 01 ~¦ 1~ CO
~ ~ JJ 0 U~ ~ ~ ~ I~ a~ t~ ~
~: Q) ~ ~ ~ ~
,1 ~ ~ ~ m o~ ~ ; i
o~ . .
Id ~ ~ O .IL1 ~ N~r q-l
E~ ~: ~ ~ ~U) ~ ~ 1 O
~ ~ 0
~ ~ ~ ~ ~ ~ CD ~ a
--~ ~U~ o o
::
~?
~ __ .
:~ h 0~ ~
6q~ O O O O O O e
, . O ~ e: o o o o o
~n ~ ~ ~ ~ ,~
_I . ~ - ~ 11
P - . . . . .
_I O ~ ~ ~
.0 2 G o
m ~ u ~ _ P
.

--73--
~
, __ ~ .~
D O a~
~ O e~
~ ~ ~ ~D W ~ O
~-_ ~ ~ ~
~ O ~
O ~ W ~ ~J ~
1~ ~1 O N ~PN ~1 ~
~ O Ll ~,
~ ~ ~ r~ In ~ ~ O D~
O _l o) ~ r~ u~ ut
I~ ~ ~ ~ o~
_ E ~i ~r r 1~ V O ~C
O O ~ ~ ~ ~
~ o 5 ~ v ~ n ~3 V ~
'a~1 D O ~ m . ~3 D o
~U ~ 1 ~~_~ ~ X ~ C1
x o ~ r~ t c ~
~ .. ~ ~ .o ~ ~ ~ '1
~: _ ~ O ~ U .
0~ C
~n OO c~ J
E ,~ N a , @
_ ~ r ~ ~
~ 3 ~ '~ C e, ~
C O 4 lO,.~j O
~I l~ ~ , 1~
~1 ~

--74
.. ~ ~ ,, . l
~1 ~ r~ o ~ o o ~ o o ~ o o o
81 ~ ~ N N N ~1 ~1 N le N ~ 1
~Sl ~ ~ ~ A ~ ~. ~ ~ A ~ ~ .
e~ Sr
V ~ ~r o ~ ~ u~
¦ ~1 Ul o ~D
~1 0 0 ~q ~ O O
. ~ I~ ~~ ~ I~ r~
O ~ _~ ~ ~D N Iq O ~
~I ~11 .'1 1~ IP O Y~~ u~
0 1 ~ 1-~ -'1 1~ ~1U~ It~ U)
.IC _1 ~ ~ ~ O ~ ~ ~1
~J ~ 2~ ~ 1 ~ u~
~ E ~1 --I N ~1 ~ Irl N N U) qr '1 ~'1
~ 1: J~ ~ ~ ~ P O ~
~ -l O
1~3 c4 ~ t~ .~ ~
~D 8 0 ~ O N ~ ~ i ,.
_I C QY) ~ A _~ ~1Irl O
;~ _l O Q- ~i
_~ _~
O C~ ~ O O O O O O O
x s se ~ o o o o c:, o o c, o
3 ~ Y A ,.~ N ~ A ~ A A
O ~ _ ~ _
v ~v m
~ ~ ~ ~ O O O O ~0 O O O O O O
_1 ~ ~ O ~ Pt ~ ~I
- x x ~e ~ K ~ K X ~: X ~
-I L) ~; O ~ U7 ~ S^ ~ ~'
U ~4 , _ , ~, _,. __,_,, _ ,,, , _, _ _,, _ _, , , , ,
~ ~ C~ o ~ ~ ~ ~ o ~r O
.1: X h. u~ ~ . ~ . ~ .
~ ~ ~ .. ~_ ,U3 ~ , 1~

-75-
., _ _~ _~
ul M ~ o n o
01 __
0~
X ~ ~P. _.1
C ~ ~1 ~
_1 ~ 10
oo Ul --~ :~
. .. .. .. ., O
_~ ~ u~ u) ~
N ~1 ff ~
~_~ t'~ 7 ~a
m L .- .. .. .. Il~
~ ~ ~) ~1 ~ r- IJI
S ~ ~ _l . O
~ ~1 .~C C~
_~
P~
~ I _~
1:: ~ _ ~ - . ~ o
3 ~: C:~ ~ ~ D _l
.. ,~
U ~ C
:3 ~ ~
~ ~a ~ ~ . u~ ~ o
R h O rl - "
~ P~ ~ V _I
O ~ ~ . o~ -
V aJ E~ X ~cr ~ O
tl~ ~ O _I ~ I
a
~ ~ P~ ~,
_l ~ _l
I Tl O O O
o aL ~ o o o
~ ~ ~_1
X ~C _ ~ ~A ~ C
4~ ~ .
O ~ ~ oo Q C:
a) c: u~ u
4~ Q~ OO O -
-I O t: ~ 1
a _I
XX ~ ~ a~
~ ,0 ~ ~ ~
U Id ______ U ~ m
~ _ .~
:1 . ~n ~ . ~ G 3
~. ~ ~ x ~ ou~ ~ ~ .
~ ~ o ~ ¢
.
.
.

--76--
_ _
~ 9
o ~ o o ~
~-. o ~ ~ ~ ~ o ~ V
N N ~ ~ ~ X 3C
e ,~
~ ~ : ` U 1~0
C ~-1 _ ~ r~ ~ ", .~,u~ 1` K 3
o ~.1 .. .. _ O
I` Cr. ~ Z
ES ~:1 Ul Y't C~
~ ~ ~1 e .. ~ ~ . . ~ ~
,~, 1~ g ¦ ~ _I N W . N D 1` ~.D r~ 111~ 111
d~ ~ ~ D ~'1 . C
~3 ~ ~3 ~ ~ O~ N !~ C
o c 5 u~ ~ ~~ ~ ~ 0_
~ ~ 31 ~ _ ~ C ~ o
01 ~ ~ 31 ~ ~1 o o c~ O o 1~ u
C ~ _ _ _ . . ID ~ ~1
~ o o ~ ~ c ~
~ ~ ~ ~ 5 ~ ~ ~ ~ ~
t~ ' ~ :~ a Q !j ", 1_l
: ~ ~ æ ~ __ _ ~ t, C r
o C E ~ ~D m m m m ~ c
~ ~ ~ C O ~ ~ 0 ~ C
Z~ K # K X K K ~ e
~~ u~ ~
_ . .~ 0 ~ ~ o
~ ~ ~ c~ u ~
g, o ~ e ~ C ul C ul D ~n Q) X ~ ~
~( ~ .c ~ ~ m 0 0 8 ~ u r~ u r. u r. u ~ e ~
~ ~ . ,~ ~
,P sl ~! o ~ ¢ 0 8
'''~`.) ~
r"

--7 7--
_ _ ____ _. _ _~
' . O ~ ~U
o a) ~-1 0~1 ,_,
~D ~ O t- ~O O ~ CU~
. O O O O O ,i
~ ~r ,~ _ t, ~
O O V o 15~ N V ,~ CO _
~,:1 . ~ _ _ ___
I e - I V I -- ¦ I I N
,~ a~ $~ ____ _ .
~i _I ~ ~ 0'~0 N N CU~ N ~O ~O
a) ~ ~ ~ ~ c~ ,i c~ o r-i 1~ E~
o a~ o Q) , . _
~_ ~ ~ ~ cu ~-
~i O E~ O ~ N N _ ~I N N ~0 O
~1 _ . _ _ __ I ~1
_~ .~_ ~_ ~ ~ _ ~
~ L~ r i N 0 3 o ~o ~ N .:t C Cl~ ~?
O _ r1 _ _ ~_ ~,_ ~ 135
O . - _. _ _ -. _. ._ _ _ ,~ _ . . C ~ O
~ ~._ IS~ O O N O O~, C Pi ~D
_ . ~ .. _~ _
O ¦ ~ ~ N ~ N C~ a ~
. ~

--78,
_ ~ _ - . . .
. ~ _~. __ _~
O ~ ~ O
1~ ~ . I . I U) . I
_1 O O ~ O. O ~0
.__ _ ~ _ _
~ 0 ~ ~D
O ~D ~D~ 0~ 0
~1 O CU ~ C~J O
V ri C~ O - O r-~
5: - . ~ . ~_
0 ~1 ~ 0 ~ ~
h 0 1 ::~ ~--1 1 0 1
t~ 1 ~ 1~ C~ O
t~ ~: C~ 1~ ~ O ~i CJ CU
~3 ~rl _ _~ _ _ ~ _~
~ _ ._ _. . _ . . I
W ¢ 0 _._ _~ ~ 0~
h ~ o~If~ 0~ 0~ 0 r-l _I NCU ~ lr~Ln ~:
~ $ ~N 0~ ~ ~t~ CU CU ~D o ::~ ~ 0
O ~ ~ ~ ~1
~1 ~ .~. ~. _- __ . _~
E~ ~ ~ C'J ~ ~ î- ,_ ~1' g
O ~ ~D U~ mC~ ~C~J ~ U~ ~ ~
I~ -i 1~ C~ 1~ ~ ~ ~ ~:
. __ ~ 'D _ ~ ~0
~U~ ~ ~C~i ~ ~ ~ o~û~
~1 ~D, ~ )~ ~U ~U~ ~
CIJ O U~ CU ~ ~ U~
__ __ ___ _ ~ s: ta o ~1
Q ~ ~U ¦ ¦ o ~ O ¦ ¦ h
..._ __ ___ _,...._ . ,_. R.
~ lo

-79-
. ~
~ , __o~ , __
,1 V ~0 C~ CU~ o C~0
__ _ _ _ _ _ .
_. _~ ~ _~ ~ ~
~ ~ O~
C~ C~ l ~ I CU o~
~1 ~iC~CD ::t ~ C~l ~~
. V o ~i ~1 ,i CU
. ~ __ _ _ . ____ .
~ ~ ~ ~D, 0 ~
,~ ~ C~ CU ,~ ~ C~ U~ ~U~ ~,_
~3 0 ~ ~ ~ ~ ~ ~I ~ ~ CU `~
C3 ~1 ~ ~ ~ ~ CU ~ t~ ~ ~ I
b~~1 O '1~. CU .'1 ~_ _~,,
o~ _ _~ C~
~ ~ ~1 _~ ~U ~U ~ m :~:
~:~ ~ ~ :t~ ~ ~ ~ ~ ~ ~
h 9.~ 0 ~ ~ ~ ~'~D . ~ . ~ ~C~ ~ ~ 0
a) ~ ~D ~ ~1 . 1<~ 1 ~D ~ 1~ ~ 1~ . I
- ,D. ` 5; O tU pt~ r-~ r ~l 1~ 3
~: ~ ~ _ _ _ _ = -
. ~ ~ ~ ~ ,_ ,_ C; ~1 ................ ~
S: OCU ~0 ~0 1~ 00 ~ ~ J O
C~ ~ ~ ~ I ~ ~ t)
~ i ~ ~ C~i ~ ~ 0
. ~ . __ _ _
,~ _~ ~ _ CU ._ ' p,t) ~
~,i ~ cr~ ~D ~ ~D ~ ~tD
I . . ~ i I I . I h a~ ~ O
~1 ~ ~0 ~ ~ t-~l ~
. ~ ~ ~ ~U C~ ~ ~ ~1
.. . _ ~ _ ~_ _ U~ 0
--W -------- ----- '~ Q'
~ U~ O O U~ O O
.~ o ~3 cu ~ C:) C~ ~ O
, ._. . h
._ _ . _ ~ . , ......... ~., . P.
~D ~ ~D ~
O 0~ ~ 0~ ~ ~ ~a o
o ~ ~ ~:~q ~ ~ ~
m ~ ~ ¢

--80-- .
The compounds of the present invention are thus
useful, given orally and parenterally, iEor enhanc:ing the
effectiveness of ~-lactam ar~tibiotîcs against ~-lac~amase
producing bacteria. On a weight basis, the dosage i~ from
one-fifth to fi~re times, ana preferably equal to, that of
th~ B-lactam a~tibiotics., As an exampl~, ~he compounds of
the present invention as shown above when U9ed il'l a 1: 1
ratio markedly improved the activity of ceforanide and
a~noxicill i~ against ~-lactamase producing strain~ o~
anaerobic Bacteroides such as B. fragilis ~ B. thetaiotaomicron
and other species s~ ~at genus and also against resis~ant
J l~ aureus. q~e compounds of the present
inverltion are given eith~r in adm~ture with or concomitantly
wit:h 'che ~-lactam antibi~tic with the dosage within the
indicate~l ratio to the kno~ an~ cu~tomary dosage of the
~tibiotic .
:: ~
~ hus, the ability of ~e coMpounds o~ the present
~n~7ention to enhance the ePfectiveness of a ~-lactam an~-
biotic again3t certain ~-lac~amase producing ~acteria makes
them ~aluabl~ for co-adminis~xa~ion with certain ~ ctam
antibiotics in the treatment of bactexial infections in
mammals, particularly ~an. In the treatment o~ a bacterial
infection, a compound o~ th~ present invention can be co-
mingled with the ~-lactæm antibiotic, and the two agent~
; thereby administered simultaneou~ly. Alternatively, a
compound o the present invention can be a~ministered as
a ~eparate ag~nt during a cour~e of treatment with a
B-lacta~ a~tibiotic.
:

Wherl using a compound of the prese~t invention
or salt t~ereof, to enhance the antibactlerial activity of
a ~-lactarn antibiotic, it can be adminis tered alone, or
preferably, in ~o~mulation with sta~dard pharmaceutis::al
carri~rs and diluents. A compound of the present invention
which is irl t.he acid form or.as a pharmaceutically-
acceptable sal~ thereof, can be administered orally or
parenterally; a compound of the present invesltiv~ in the
form of an est~r which i~ readily hydrolyzable ~n r vo, is
best adminis1:ere~ orally. Parenteral administration includes
intramuscular, subc:utaneous, intraperitoneal and in~a-
venous administration.
When a compo~ind of the preserlt inventic~ is used
in the presence of a ca~ r or diluent, said carrier or-
diluent is chose~ on the basis of the intended mode of
aaministration. ~or example, when consider ~ g the oral.
m ~ e o administration,.the compound can be used ~n the
form of tablets,.capsules,.lozenges, troches, powdersl.
syrups~ elixir~, aqueous solutions and ~uspensio~s, aYla the
like, in accordance with standard pharmac~utical practice.
~he proportional ~atio of acti~e ingredients to carrier will
naturally depend on the chemical naturef solubility,
stabili~y and potency of the active ingredients, as well as
the dosage contempl~ted. However, these pharmaceutical
co~positions will likely contain ~rom about 5~ to about
80% of caxrier. In the case o~ tablets ~or oral use,
carriers which are commonly used include l~ctose, sodium
citrate and salts of phosphoric acid. Various disintegrants
such as starch, and lubricating agents, such as magnesium
stearate, qodium l~uryl sul~te and talc, are commonly
u~ed i~ tablets. For oral administration in cap$ule ~orm,
useful diluents are lac~ose ~nd high molecul~r weight
;~
.

--8 2~
~:~Lt7S~
polyethylerle glyco:Ls~ When aqueous susp2nsions are
re~uired for o~al use, the acti~re ingredies~ts are combined
with emulsifying and suspend~g agents~. If desired, certain
sweetening and/or f lavoring agents can ~e added. For
parenteral administration, which inc:ludes intramuscular,
intraperitoneal ~ subcutaneous and intravenous us~, steril~s
solutions of the ac~ive ingredients are usually prepared,
and the pH or the solutions are suitably adjusted and
bu~fered. For intravenous use, the total concentration of
solutes should be controlled to render ~he preparation
isotonic.
Although the prescribing physician will ultimately
decide the dosage to be used in a human subject, the ratio
of ~he daily aosages of a compound o~ the present invention,
or salt thereof~ and the ~-lactam antibiotic will normally
be in the range from about 1:5 to 5:1, and preferably abou~
1:1. Additionally, the daily oral dosage of each component
wîll normally be in the range rom about 10 to about 200 mg.
per kilogram o~ body weight and the daily parenteral dosage
of ea~h component will normally be about 10 to about 100 mg.
per kil~gram of body weight~ These figures are illustrative
~ .. __ . _ . . .. . . . ... _ ., _ _ , _ ,,_, , ~_
only, however, and in some ca~es it may be necessary to
u~e dosages outside these l~mit~.
This invention i~ capable of industrial
appl ication .
:". '

Representative Drawing

Sorry, the representative drawing for patent document number 1175809 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: Expired (old Act Patent) latest possible expiry date 2001-10-09
Grant by Issuance 1984-10-09

Abandonment History

There is no abandonment history.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
BRISTOL-MYERS COMPANY
Past Owners on Record
WILLIAM J. GOTTSTEIN
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column (Temporarily unavailable). To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Cover Page 1993-12-15 1 20
Abstract 1993-12-15 1 7
Claims 1993-12-15 5 105
Drawings 1993-12-15 1 23
Descriptions 1993-12-15 82 2,658